Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
C1QB	713	broad.mit.edu	37	1	22987519	22987519	+	Silent	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr1:22987519G>A	ENST00000509305.1	+	3	742	c.396G>A	c.(394-396)ctG>ctA	p.L132L	C1QB_ENST00000314933.6_Silent_p.L134L			P02746	C1QB_HUMAN	complement component 1, q subcomponent, B chain	134	C1q.	NA			complement activation, classical pathway|innate immune response	collagen|complement component C1 complex				breast(1)|endometrium(2)|large_intestine(1)|lung(9)|prostate(1)	14		Colorectal(325;3.46e-05)|Lung NSC(340;6.55e-05)|all_lung(284;9.87e-05)|Renal(390;0.000219)|Breast(348;0.00262)|Ovarian(437;0.00308)|Myeloproliferative disorder(586;0.0255)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0227)|OV - Ovarian serous cystadenocarcinoma(117;7.06e-27)|Colorectal(126;1.58e-07)|GBM - Glioblastoma multiforme(114;6.72e-06)|COAD - Colon adenocarcinoma(152;1.13e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000551)|KIRC - Kidney renal clear cell carcinoma(1967;0.0027)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.198)	Abciximab(DB00054)|Adalimumab(DB00051)|Alefacept(DB00092)|Alemtuzumab(DB00087)|Basiliximab(DB00074)|Bevacizumab(DB00112)|Cetuximab(DB00002)|Daclizumab(DB00111)|Efalizumab(DB00095)|Etanercept(DB00005)|Gemtuzumab ozogamicin(DB00056)|Ibritumomab(DB00078)|Immune globulin(DB00028)|Muromonab(DB00075)|Natalizumab(DB00108)|Palivizumab(DB00110)|Rituximab(DB00073)|Tositumomab(DB00081)|Trastuzumab(DB00072)	ACGTCCCCCTGCGCCGGGACC	0.597	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						127	119	122	NA		NA	NA	1		NA											NA				22987519		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000173369	HGNC:1242	NM_000491	Approved	uc001bgd.3	NA	Q5T959|Q96H17	ENST00000509305.1	37																																																																																				C1QB-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000008092.2	-136.881665	KEEP		+	7.18208	0.011407	6	520	---	---	---	---	1	0.9997546	2	1296	0	169	9	715	0	169	2	0	0	0	0	0	0	9	715	0	169	2	TP
SZT2	23334	broad.mit.edu	37	1	43905598	43905598	+	Silent	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr1:43905598G>A	ENST00000562955.1	+	50	6918	c.6918G>A	c.(6916-6918)ggG>ggA	p.G2306G	SZT2_ENST00000372442.1_Silent_p.G1464G	NM_015284.3	NP_056099.3	Q5T011	SZT2_HUMAN	seizure threshold 2 homolog (mouse)	2363		NA				peroxisome				NS(2)|breast(9)|central_nervous_system(1)|endometrium(17)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(19)|lung(39)|ovary(4)|pancreas(3)|prostate(4)|skin(2)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(3)	113						GGGAAAAGGGGAACATTAGTA	0.567	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						83	86	85	NA		NA	NA	1		NA											NA				43905598		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000198198	HGNC:29040	NM_015284	Approved	uc001cjk.3	NA	A0PJK5|A7E2X4|O75055|Q5JUY7|Q5T012|Q5XKC7|Q6ZNI8|Q6ZT24|Q7Z636|Q8NAY9|Q9H5H7|Q9UFQ8	ENST00000562955.1	37	CCDS30694.2																																																																																			SZT2-004	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000019517.3	112.362032	KEEP		+	112.681274	0.575758	38	28	---	---	---	---	1	0.9999983	18	7	0	176	42	35	0	176	2	0	0	0	0	0	0	42	35	0	176	2	TP
DAB1	1600	broad.mit.edu	37	1	57535099	57535099	+	Splice_Site	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr1:57535099C>T	ENST00000371236.2	-	8	861		c.e8-1		DAB1_ENST00000485760.1_Splice_Site|DAB1_ENST00000414851.2_Intron|DAB1_ENST00000371231.1_Splice_Site|DAB1_ENST00000439789.2_Intron|DAB1_ENST00000371234.4_Splice_Site|DAB1_ENST00000420954.2_Intron			O75553	DAB1_HUMAN	Dab, reelin signal transducer, homolog 1 (Drosophila)	NA		NA			cell differentiation|nervous system development					central_nervous_system(1)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(12)|lung(28)|ovary(3)|skin(4)|upper_aerodigestive_tract(5)|urinary_tract(5)	64						ACACAATGTACTATTACAGGA	0.413	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						103	97	99	NA		NA	NA	1		NA											NA				57535099		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000173406	HGNC:2661	NM_021080	Approved	uc001cys.1	NA	A4FU90|B3KTG3|Q4LE59|Q5T6M6|Q5T6M9|Q5T835|Q5T836|Q5T837|Q6NWS9|Q6NWT0|Q6NWT1|Q9NYA8	ENST00000371236.2	37	CCDS607.1	.	.	.	.	.	.	.	.	.	.	C	27.7	4.854344	0.91355	.	.	ENSG00000173406	ENST00000371236;ENST00000371233;ENST00000371234;ENST00000371231	.	.	.	5.53	5.53	0.82687	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	19.6556	0.95837	0.0:1.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	-	.	.	DAB1	57307687	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.320000	0.79064	2.882000	0.98803	0.655000	0.94253	.	DAB1-004	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000027814.2	20.320232	KEEP	Intron	-	20.71669	0.35	7	13	---	---	---	---	1	0.9997867	8	28	0	127	9	14	0	127	2	0	0	0	0	0	0	9	14	0	127	2	TP
FPGT-TNNI3K	0	broad.mit.edu	37	1	74665467	74665467	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr1:74665467C>T	ENST00000370895.1	+	2	237	c.202C>T	c.(202-204)Ctt>Ttt	p.L68F	LRRIQ3_ENST00000354431.4_5'Flank|FPGT_ENST00000370898.2_Missense_Mutation_p.L68F|FPGT_ENST00000534056.1_Missense_Mutation_p.L68F|TNNI3K_ENST00000370893.1_Missense_Mutation_p.L68F|LRRIQ3_ENST00000370911.3_5'Flank|FPGT-TNNI3K_ENST00000557284.1_Missense_Mutation_p.L68F|FPGT_ENST00000370894.4_Missense_Mutation_p.L68F|FPGT_ENST00000524915.1_Missense_Mutation_p.L68F|LRRIQ3_ENST00000370909.2_5'Flank|FPGT-TNNI3K_ENST00000370899.3_Missense_Mutation_p.L68F|FPGT_ENST00000467578.2_Missense_Mutation_p.L68F|TNNI3K_ENST00000370891.2_Missense_Mutation_p.L68F|FPGT_ENST00000482102.2_Missense_Mutation_p.L90F			Q59H18	TNI3K_HUMAN		0		NA				cytoplasm|nucleus	ATP binding|metal ion binding|protein C-terminus binding|protein serine/threonine kinase activity|troponin I binding				NA						GGAGTTACCCCTTGGAGTTCA	0.403	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						146	139	142	NA		NA	NA	1		NA											NA				74665467		2203	4300	6503	SO:0001583	missense								NA	Q17RN0|Q49AR1|Q6MZS9|Q9Y2V6	ENST00000370895.1	37		.	.	.	.	.	.	.	.	.	.	C	21.9	4.212180	0.79240	.	.	ENSG00000254685;ENSG00000254685;ENSG00000254685;ENSG00000254685;ENSG00000254685;ENSG00000254685;ENSG00000254685;ENSG00000259030;ENSG00000259030;ENSG00000259030;ENSG00000259030;ENSG00000116783;ENSG00000116783	ENST00000467578;ENST00000524915;ENST00000482102;ENST00000370898;ENST00000370894;ENST00000534056;ENST00000472069;ENST00000370899;ENST00000370895;ENST00000534632;ENST00000557284;ENST00000370891;ENST00000370893	T;T;T;T;T;T	0.76448	1.46;0.88;-1.02;-0.72;-1.01;-1.01	4.79	3.86	0.44501	.	0.096519	0.43110	D	0.000618	T	0.77883	0.4197	L	0.50333	1.59	0.26896	N	0.967227	P;D;D;D;B;B	0.76494	0.654;0.999;0.99;0.982;0.013;0.44	B;D;P;P;B;B	0.68765	0.349;0.96;0.776;0.839;0.013;0.127	T	0.69764	-0.5057	10	0.66056	D	0.02	.	12.4091	0.55457	0.0:0.917:0.0:0.083	.	68;68;68;68;68;68	B4DH62;E9PNQ2;Q59H18-1;Q59H18-4;Q59H18-3;O14772	.;.;.;.;.;FPGT_HUMAN	F	68;68;90;68;68;68;66;68;68;68;68;68;68	ENSP00000359935:L68F;ENSP00000432819:L68F;ENSP00000359936:L68F;ENSP00000359932:L68F;ENSP00000450895:L68F;ENSP00000359928:L68F	ENSP00000359928:L68F	L	+	1	0	RP11-653A5.2;TNNI3K;AC093158.1	74438055	0.976000	0.34144	0.994000	0.49952	0.994000	0.84299	2.410000	0.44592	2.345000	0.79718	0.585000	0.79938	CTT	FPGT-TNNI3K-002	NOVEL	basic|readthrough_transcript	protein_coding	NA	protein_coding	OTTHUMT00000412971.1	96.222027	KEEP		+	98.342694	0.962963	26	1	---	---	---	---	1	1	20	10	0	242	29	1	0	242	2	0	0	0	0	0	0	29	1	0	242	2	TP
PDE4DIP	9659	broad.mit.edu	37	1	144854614	144854614	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr1:144854614C>T	ENST00000369359.4	-	45	7302	c.7264G>A	c.(7264-7266)Gta>Ata	p.V2422I	PDE4DIP_ENST00000524974.1_5'UTR|PDE4DIP_ENST00000530740.1_Missense_Mutation_p.V2371I|PDE4DIP_ENST00000313382.9_Missense_Mutation_p.V2180I|PDE4DIP_ENST00000369354.3_Missense_Mutation_p.V2286I|PDE4DIP_ENST00000369356.4_Missense_Mutation_p.V2286I			Q5VU43	MYOME_HUMAN	phosphodiesterase 4D interacting protein	2286		NA			cellular protein complex assembly	centrosome|Golgi apparatus|myofibril|nucleus	enzyme binding			NS(1)|breast(3)|central_nervous_system(2)|cervix(2)|endometrium(15)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(12)|lung(106)|ovary(8)|prostate(7)|skin(3)|upper_aerodigestive_tract(4)|urinary_tract(2)	176				Colorectal(2;0.0829)|COAD - Colon adenocarcinoma(2;0.126)		TGTTTGGATACTTTGGTTCTC	0.498	NA	NA	T	PDGFRB	MPD									NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		1	1q12	9659	phosphodiesterase 4D interacting protein (myomegalin)		L	0							NA						270	229	243	NA		NA	NA	1		NA											NA				144854614		2203	4300	6503	SO:0001583	missense			ENSG00000178104	HGNC:15580	NM_022359	Approved	uc021ouh.1	NA	A2RU15|O75042|O75065|Q2YDC1|Q5VU42|Q5VU44|Q5VU45|Q5VU46|Q5VU47|Q5VU48|Q5VU49|Q68DU2|Q6AZ93|Q6PK88|Q86T40|Q86TB2|Q8N3W0|Q8TAY9|Q9HCP2|Q9HCP3|Q9HCP4|Q9HCP5	ENST00000369359.4	37		.	.	.	.	.	.	.	.	.	.	.	7.008	0.556228	0.13436	.	.	ENSG00000178104	ENST00000313382;ENST00000369354;ENST00000369356;ENST00000530740;ENST00000369359	T;T;T;T;T	0.01474	4.85;4.94;4.93;4.91;4.94	4.0	-1.75	0.08031	.	.	.	.	.	T	0.00384	0.0012	N	0.20685	0.6	0.21841	N	0.999511	B;B	0.02656	0.0;0.0	B;B	0.04013	0.001;0.001	T	0.45454	-0.9260	9	0.41790	T	0.15	.	1.5846	0.02641	0.1841:0.4502:0.1586:0.2071	.	2180;2286	Q5VU43-3;Q5VU43	.;MYOME_HUMAN	I	2180;2286;2286;2371;2422	ENSP00000327209:V2180I;ENSP00000358360:V2286I;ENSP00000358363:V2286I;ENSP00000435654:V2371I;ENSP00000358366:V2422I	ENSP00000327209:V2180I	V	-	1	0	PDE4DIP	143565971	0.334000	0.24739	0.031000	0.17742	0.451000	0.32288	0.263000	0.18478	0.019000	0.15079	-0.656000	0.03901	GTA	PDE4DIP-037	NOVEL	not_organism_supported|basic	protein_coding	NA	protein_coding	OTTHUMT00000384689.1	177.948323	KEEP		-	187.937564	0.282051	66	168	---	---	---	---	1	1	8	78	0	487	77	193	0	487	2	0	0	0	0	0	0	77	193	0	487	2	TP
MRPL30	51263	broad.mit.edu	37	2	99811636	99811636	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr2:99811636G>C	ENST00000338148.3	+	5	535	c.337G>C	c.(337-339)Gtt>Ctt	p.V113L	C2orf15_ENST00000512183.2_Missense_Mutation_p.V113L|MRPL30_ENST00000410042.1_Missense_Mutation_p.V113L|MRPL30_ENST00000465432.1_3'UTR	NM_145212.3	NP_660213.1	Q8TCC3	RM30_HUMAN	mitochondrial ribosomal protein L30	113		NA			translation	mitochondrion|ribosome	structural constituent of ribosome			breast(1)|endometrium(1)|kidney(1)|lung(4)|ovary(1)|prostate(1)|upper_aerodigestive_tract(1)	10						ATTGAAAGTAGTTAAGCATTT	0.333	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						180	174	176	NA		NA	NA	2		NA											NA				99811636		2203	4300	6503	SO:0001583	missense			ENSG00000185414	HGNC:14036		Approved	uc002szv.3	NA	A6NIC6|D3DVI0|D3DVI3|Q0D2Q7|Q6ZTP4|Q96Q69|Q9P0N0	ENST00000338148.3	37	CCDS2041.1	.	.	.	.	.	.	.	.	.	.	G	19.07	3.756927	0.69648	.	.	ENSG00000241962;ENSG00000241962;ENSG00000185414;ENSG00000185414;ENSG00000185414	ENST00000512183;ENST00000308644;ENST00000410042;ENST00000338148;ENST00000409841	T;T;T	0.60797	0.16;0.16;0.16	4.43	4.43	0.53597	Ribosomal protein L30, ferredoxin-like fold domain (3);	0.206931	0.42964	D	0.000621	T	0.71221	0.3314	M	0.88377	2.95	0.37937	D	0.932202	D;P	0.59767	0.986;0.936	P;P	0.55260	0.772;0.64	T	0.78605	-0.2139	10	0.72032	D	0.01	-17.6991	8.5108	0.33215	0.103:0.0:0.897:0.0	.	113;113	Q8TCC3;Q8TCC3-3	RM30_HUMAN;.	L	113;126;113;113;113	ENSP00000420959:V113L;ENSP00000338057:V113L;ENSP00000386752:V113L	ENSP00000312464:V126L	V	+	1	0	C2orf15;MRPL30	99178068	1.000000	0.71417	0.997000	0.53966	0.871000	0.50021	1.834000	0.39171	2.455000	0.83008	0.655000	0.94253	GTT	MRPL30-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253130.2	387.204961	KEEP		+	398.705478	0.804511	107	26	---	---	---	---	1	1	42	94	0	194	136	32	0	194	2	0	0	0	0	0	0	136	32	0	194	2	TP
TTN	7273	broad.mit.edu	37	2	179396630	179396630	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr2:179396630T>G	ENST00000589042.1	-	358	104936	c.104712A>C	c.(104710-104712)agA>agC	p.R34904S	TTN-AS1_ENST00000591332.1_RNA|TTN-AS1_ENST00000590040.1_RNA|TTN-AS1_ENST00000591466.1_RNA|TTN_ENST00000342175.6_Missense_Mutation_p.R26031S|TTN-AS1_ENST00000592836.1_RNA|TTN-AS1_ENST00000592182.1_RNA|TTN_ENST00000359218.5_Missense_Mutation_p.R25964S|TTN-AS1_ENST00000604571.1_RNA|TTN-AS1_ENST00000588804.1_RNA|TTN-AS1_ENST00000587944.1_RNA|TTN-AS1_ENST00000589391.1_RNA|TTN-AS1_ENST00000588716.1_RNA|TTN_ENST00000460472.2_Missense_Mutation_p.R25839S|TTN-AS1_ENST00000592689.1_RNA|TTN-AS1_ENST00000585487.1_RNA|TTN-AS1_ENST00000450692.2_RNA|TTN-AS1_ENST00000592600.1_RNA|TTN_ENST00000342992.6_Missense_Mutation_p.R32336S|TTN-AS1_ENST00000589434.1_RNA|TTN-AS1_ENST00000588244.1_RNA|TTN-AS1_ENST00000586831.1_RNA|TTN-AS1_ENST00000442329.2_RNA|TTN-AS1_ENST00000592750.1_RNA|TTN-AS1_ENST00000592630.1_RNA|TTN-AS1_ENST00000591867.1_RNA|TTN-AS1_ENST00000588257.1_RNA|TTN-AS1_ENST00000586707.1_RNA|TTN-AS1_ENST00000590807.1_RNA|TTN-AS1_ENST00000585451.1_RNA|TTN-AS1_ENST00000586452.1_RNA|TTN-AS1_ENST00000585625.1_RNA|TTN-AS1_ENST00000419746.1_RNA|TTN-AS1_ENST00000585358.1_RNA|TTN-AS1_ENST00000431259.2_RNA|TTN-AS1_ENST00000589842.1_RNA|TTN_ENST00000591111.1_Missense_Mutation_p.R33263S|TTN-AS1_ENST00000456053.1_RNA|TTN-AS1_ENST00000587568.1_RNA|TTN-AS1_ENST00000589355.1_RNA	NM_001267550.1	NP_001254479.1	Q8WZ42	TITIN_HUMAN	titin	33263		NA					ATP binding|nucleic acid binding|protein serine/threonine kinase activity|protein tyrosine kinase activity			NS(24)|autonomic_ganglia(1)|breast(64)|central_nervous_system(14)|cervix(14)|endometrium(96)|haematopoietic_and_lymphoid_tissue(16)|kidney(91)|large_intestine(303)|liver(1)|lung(595)|ovary(58)|pancreas(17)|prostate(38)|skin(60)|stomach(29)|upper_aerodigestive_tract(1)|urinary_tract(26)	1448			OV - Ovarian serous cystadenocarcinoma(117;0.023)|Epithelial(96;0.0454)|all cancers(119;0.134)			AGATATCAAATCTTGCAGACC	0.453	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						63	57	59	NA		NA	NA	2		NA											NA				179396630		1910	4124	6034	SO:0001583	missense			ENSG00000155657	HGNC:12403	NM_133378	Approved	uc031rqd.1	NA	E7ET18	ENST00000589042.1	37	CCDS59435.1	.	.	.	.	.	.	.	.	.	.	T	12.28	1.889881	0.33348	.	.	ENSG00000155657	ENST00000342992;ENST00000460472;ENST00000342175;ENST00000359218;ENST00000356127	T;T;T;T	0.71222	-0.55;-0.3;-0.32;-0.33	5.56	4.41	0.53225	Peptidase C2, calpain, large subunit, domain III (1);Ribonuclease H-like (1);	.	.	.	.	T	0.63105	0.2483	N	0.24115	0.695	0.37604	D	0.920676	P;P;P;P	0.52463	0.953;0.953;0.953;0.953	P;P;P;P	0.50109	0.556;0.556;0.556;0.631	T	0.68447	-0.5406	9	0.87932	D	0	.	8.4818	0.33047	0.0:0.149:0.0:0.851	.	25839;25964;26031;33263	D3DPF9;E7EQE6;E7ET18;Q8WZ42	.;.;.;TITIN_HUMAN	S	32336;25839;26031;25964;25836	ENSP00000343764:R32336S;ENSP00000434586:R25839S;ENSP00000340554:R26031S;ENSP00000352154:R25964S	ENSP00000340554:R26031S	R	-	3	2	TTN	179104876	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	1.033000	0.30191	0.952000	0.37798	0.528000	0.53228	AGA	TTN-018	PUTATIVE	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000450680.2	9.491744	KEEP		-	10.401286	0.25	4	12	---	---	---	---	1	0.9356356	5	0	0	30	13	14	0	30	2	0	0	0	0	0	0	13	14	0	30	2	TP
GOLGB1	2804	broad.mit.edu	37	3	121410932	121410932	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr3:121410932C>T	ENST00000393667.3	-	14	7389	c.7279G>A	c.(7279-7281)Gag>Aag	p.E2427K	GOLGB1_ENST00000340645.5_Missense_Mutation_p.E2422K	NM_001256486.1	NP_001243415.1	Q14789	GOGB1_HUMAN	golgin B1	2422		NA			Golgi organization	ER-Golgi intermediate compartment|Golgi membrane|Golgi stack|integral to membrane	protein binding			NS(1)|autonomic_ganglia(1)|breast(7)|central_nervous_system(2)|cervix(2)|endometrium(12)|kidney(3)|large_intestine(26)|liver(2)|lung(36)|ovary(7)|prostate(4)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(13)	119				GBM - Glioblastoma multiforme(114;0.0989)		ATATTCTCCTCTTCCTCCTGG	0.398	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						125	122	123	NA		NA	NA	3		NA											NA				121410932		2203	4300	6503	SO:0001583	missense			ENSG00000173230	HGNC:4429	NM_004487	Approved	uc010hrc.4	NA	D3DN92|Q14398	ENST00000393667.3	37	CCDS58847.1	.	.	.	.	.	.	.	.	.	.	C	11.08	1.533994	0.27387	.	.	ENSG00000173230	ENST00000340645;ENST00000393667	T;T	0.15487	2.42;2.42	5.79	5.79	0.91817	.	0.000000	0.56097	D	0.000032	T	0.34077	0.0885	L	0.60455	1.87	0.44890	D	0.997905	D;D;B	0.65815	0.995;0.995;0.102	P;P;B	0.62089	0.898;0.898;0.077	T	0.00862	-1.1536	10	0.23302	T	0.38	.	15.5369	0.76011	0.0:1.0:0.0:0.0	.	2427;2427;2422	E7EP74;B2ZZ91;Q14789	.;.;GOGB1_HUMAN	K	2422;2427	ENSP00000341848:E2422K;ENSP00000377275:E2427K	ENSP00000341848:E2422K	E	-	1	0	GOLGB1	122893622	1.000000	0.71417	1.000000	0.80357	0.981000	0.71138	4.493000	0.60341	2.735000	0.93741	0.563000	0.77884	GAG	GOLGB1-002	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000355160.1	119.609016	KEEP		-	120.014223	0.428571	39	52	---	---	---	---	1	1	25	44	0	259	44	57	0	259	2	0	0	0	0	0	0	44	57	0	259	2	TP
TLR1	7096	broad.mit.edu	37	4	38798595	38798595	+	Missense_Mutation	SNP	G	G	A	rs144775976	byFrequency	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr4:38798595G>A	ENST00000308979.2	-	4	2131	c.1858C>T	c.(1858-1860)Cgg>Tgg	p.R620W	TLR1_ENST00000510552.1_5'Flank|TLR1_ENST00000502213.2_Missense_Mutation_p.R620W	NM_003263.3	NP_003254.2	Q15399	TLR1_HUMAN	toll-like receptor 1	620		NA			cellular response to triacyl bacterial lipopeptide|detection of triacyl bacterial lipopeptide|inflammatory response|innate immune response|macrophage activation|positive regulation of interleukin-6 biosynthetic process|positive regulation of tumor necrosis factor biosynthetic process	integral to plasma membrane|phagocytic vesicle membrane|Toll-like receptor 1-Toll-like receptor 2 protein complex	protein heterodimerization activity|transmembrane receptor activity			cervix(1)|endometrium(1)|kidney(1)|large_intestine(6)|lung(11)|ovary(1)|prostate(1)|skin(4)|stomach(2)	28						GCCCTGCGCCGGGTCTGGGTC	0.517	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(5;216 373 40795 46382)							NA				0							NA						83	90	88	NA		NA	NA	4		NA											NA				38798595		2203	4300	6503	SO:0001583	missense				HGNC:11847		Approved	uc003gtl.3	NA	O15452|Q32MK3|Q9UG90	ENST00000308979.2	37	CCDS33973.1	.	.	.	.	.	.	.	.	.	.	G	9.039	0.989172	0.18966	.	.	ENSG00000174125	ENST00000308979;ENST00000502213	T;T	0.02216	4.39;4.39	5.5	4.58	0.56647	.	0.130592	0.35096	N	0.003455	T	0.02929	0.0087	L	0.45422	1.42	0.39231	D	0.963682	B	0.18461	0.028	B	0.18871	0.023	T	0.49542	-0.8929	10	0.26408	T	0.33	.	13.174	0.59615	0.0:0.0:0.4571:0.5429	.	620	Q15399	TLR1_HUMAN	W	620	ENSP00000354932:R620W;ENSP00000421259:R620W	ENSP00000354932:R620W	R	-	1	2	TLR1	38474990	1.000000	0.71417	0.993000	0.49108	0.508000	0.34012	4.785000	0.62418	1.249000	0.43950	0.563000	0.77884	CGG	TLR1-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		141.541926	KEEP		-	141.942764	0.433962	46	60	---	---	---	---	1	0.9999576	2	23	0	244	59	77	0	244	2	0	0	0	0	0	0	59	77	0	244	2	TP
PDGFRA	5156	broad.mit.edu	37	4	55138611	55138611	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr4:55138611G>A	ENST00000257290.5	+	9	1619	c.1288G>A	c.(1288-1290)Gga>Aga	p.G430R	FIP1L1_ENST00000507166.1_Intron	NM_006206.4	NP_006197.1	P16234	PGFRA_HUMAN	platelet-derived growth factor receptor, alpha polypeptide	430	Ig-like C2-type 5.	NA			cardiac myofibril assembly|cell activation|luteinization|metanephric glomerular capillary formation|peptidyl-tyrosine phosphorylation|positive regulation of cell migration|positive regulation of DNA replication|positive regulation of fibroblast proliferation|protein autophosphorylation|retina vasculature development in camera-type eye	cytoplasm|integral to plasma membrane|nucleus	ATP binding|platelet-derived growth factor alpha-receptor activity|platelet-derived growth factor binding|platelet-derived growth factor receptor binding|protein homodimerization activity|vascular endothelial growth factor receptor activity			NS(1)|autonomic_ganglia(1)|bone(1)|breast(4)|central_nervous_system(17)|cervix(1)|endometrium(4)|eye(1)|gastrointestinal_tract_(site_indeterminate)(1)|haematopoietic_and_lymphoid_tissue(22)|kidney(6)|large_intestine(26)|liver(4)|lung(48)|ovary(4)|prostate(6)|skin(11)|small_intestine(49)|soft_tissue(727)|stomach(32)|urinary_tract(1)	967	all_cancers(7;0.000425)|all_lung(4;0.000343)|Lung NSC(11;0.000467)|all_epithelial(27;0.0131)|all_neural(26;0.0209)|Glioma(25;0.08)		GBM - Glioblastoma multiforme(1;4.18e-71)|all cancers(1;4.76e-45)|LUSC - Lung squamous cell carcinoma(32;0.00256)		Becaplermin(DB00102)|Imatinib(DB00619)|Sunitinib(DB01268)	CTCAACTGGGGGACAGACGGT	0.473	NA	NA	"""Mis, O, T"""	FIP1L1	"""GIST, idiopathic hypereosinophilic syndrome, paediatric GBM"""				Gastrointestinal Stromal Tumors, Sporadic Multiple Primary;Familial Intestinal Neurofibromatosis	TSP Lung(21;0.16)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(151;208 1913 7310 23853 37092)		Dom	yes		4	4q11-q13	5156	"""platelet-derived growth factor, alpha-receptor"""		"""L, M, O"""	0							NA						157	142	147	NA		NA	NA	4		NA											NA				55138611		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Sporadic Multiple GIST;Familial Intestinal Stromal Tumors, NF3B, subset of Familial GIST,	ENSG00000134853	HGNC:8803	NM_006206	Approved	uc003han.4	NA	B2RE69|Q96KZ7|Q9UD28	ENST00000257290.5	37	CCDS3495.1	.	.	.	.	.	.	.	.	.	.	G	4.318	0.058264	0.08339	.	.	ENSG00000134853	ENST00000257290	T	0.75938	-0.98	6.17	6.17	0.99709	.	0.000000	0.31760	U	0.007105	T	0.67401	0.2889	L	0.38175	1.15	0.80722	D	1	B;B	0.19583	0.011;0.037	B;B	0.19391	0.012;0.025	T	0.62440	-0.6854	10	0.54805	T	0.06	.	15.0188	0.71613	0.0694:0.0:0.9306:0.0	.	430;430	P16234-3;P16234	.;PGFRA_HUMAN	R	430	ENSP00000257290:G430R	ENSP00000257290:G430R	G	+	1	0	PDGFRA	54833368	1.000000	0.71417	0.774000	0.31636	0.010000	0.07245	6.327000	0.72910	2.941000	0.99782	0.655000	0.94253	GGA	PDGFRA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250598.2	786.705449	KEEP		+	802.173492	0.729231	237	88	---	---	---	---	1	1	3735	981	0	151	289	119	0	151	2	1	1	195	60	0	467	289	119	0	151	2	TP
PDGFRA	5156	broad.mit.edu	37	4	55138664	55138664	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr4:55138664G>C	ENST00000257290.5	+	9	1672	c.1341G>C	c.(1339-1341)tgG>tgC	p.W447C	FIP1L1_ENST00000507166.1_Intron	NM_006206.4	NP_006197.1	P16234	PGFRA_HUMAN	platelet-derived growth factor receptor, alpha polypeptide	447	Ig-like C2-type 5.	NA			cardiac myofibril assembly|cell activation|luteinization|metanephric glomerular capillary formation|peptidyl-tyrosine phosphorylation|positive regulation of cell migration|positive regulation of DNA replication|positive regulation of fibroblast proliferation|protein autophosphorylation|retina vasculature development in camera-type eye	cytoplasm|integral to plasma membrane|nucleus	ATP binding|platelet-derived growth factor alpha-receptor activity|platelet-derived growth factor binding|platelet-derived growth factor receptor binding|protein homodimerization activity|vascular endothelial growth factor receptor activity			NS(1)|autonomic_ganglia(1)|bone(1)|breast(4)|central_nervous_system(17)|cervix(1)|endometrium(4)|eye(1)|gastrointestinal_tract_(site_indeterminate)(1)|haematopoietic_and_lymphoid_tissue(22)|kidney(6)|large_intestine(26)|liver(4)|lung(48)|ovary(4)|prostate(6)|skin(11)|small_intestine(49)|soft_tissue(727)|stomach(32)|urinary_tract(1)	967	all_cancers(7;0.000425)|all_lung(4;0.000343)|Lung NSC(11;0.000467)|all_epithelial(27;0.0131)|all_neural(26;0.0209)|Glioma(25;0.08)		GBM - Glioblastoma multiforme(1;4.18e-71)|all cancers(1;4.76e-45)|LUSC - Lung squamous cell carcinoma(32;0.00256)		Becaplermin(DB00102)|Imatinib(DB00619)|Sunitinib(DB01268)	ATATTGAGTGGATGATATGCA	0.438	NA	NA	"""Mis, O, T"""	FIP1L1	"""GIST, idiopathic hypereosinophilic syndrome, paediatric GBM"""				Gastrointestinal Stromal Tumors, Sporadic Multiple Primary;Familial Intestinal Neurofibromatosis	TSP Lung(21;0.16)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(151;208 1913 7310 23853 37092)		Dom	yes		4	4q11-q13	5156	"""platelet-derived growth factor, alpha-receptor"""		"""L, M, O"""	0							NA						146	136	139	NA		NA	NA	4		NA											NA				55138664		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Sporadic Multiple GIST;Familial Intestinal Stromal Tumors, NF3B, subset of Familial GIST,	ENSG00000134853	HGNC:8803	NM_006206	Approved	uc003han.4	NA	B2RE69|Q96KZ7|Q9UD28	ENST00000257290.5	37	CCDS3495.1	.	.	.	.	.	.	.	.	.	.	G	14.09	2.430751	0.43122	.	.	ENSG00000134853	ENST00000257290	D	0.94966	-3.57	6.17	5.33	0.75918	Immunoglobulin-like fold (1);	0.000000	0.30538	U	0.009404	D	0.97065	0.9041	M	0.79123	2.44	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.91635	0.999;0.99	D	0.97652	1.0155	10	0.87932	D	0	.	15.6271	0.76870	0.0653:0.0:0.9346:0.0	.	447;447	P16234-3;P16234	.;PGFRA_HUMAN	C	447	ENSP00000257290:W447C	ENSP00000257290:W447C	W	+	3	0	PDGFRA	54833421	1.000000	0.71417	1.000000	0.80357	0.022000	0.10575	8.102000	0.89548	1.632000	0.50472	-0.140000	0.14226	TGG	PDGFRA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250598.2	690.407236	KEEP		+	702.306266	0.720588	196	76	---	---	---	---	1	1	3096	960	0	130	239	94	0	130	2	1	1	204	50	0	467	239	94	0	130	2	TP
TRIO	7204	broad.mit.edu	37	5	14502713	14502713	+	Silent	SNP	G	G	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr5:14502713G>T	ENST00000344204.4	+	54	8382	c.8358G>T	c.(8356-8358)gtG>gtT	p.V2786V	TRIO_ENST00000537187.1_Silent_p.V2610V|TRIO_ENST00000344135.5_Silent_p.V285V	NM_007118.2	NP_009049.2	O75962	TRIO_HUMAN	trio Rho guanine nucleotide exchange factor	2786		NA			apoptosis|axon guidance|induction of apoptosis by extracellular signals|nerve growth factor receptor signaling pathway|regulation of Rho protein signal transduction|small GTPase mediated signal transduction|transmembrane receptor protein tyrosine phosphatase signaling pathway	cytosol	ATP binding|protein serine/threonine kinase activity|Rho guanyl-nucleotide exchange factor activity			NS(2)|breast(6)|central_nervous_system(4)|endometrium(16)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(21)|lung(34)|ovary(4)|prostate(2)|skin(11)|stomach(3)|upper_aerodigestive_tract(3)|urinary_tract(4)	118	Lung NSC(4;0.000742)					GGATCATGGTGACCTGGAAAG	0.542	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						148	117	127	NA		NA	NA	5		NA											NA				14502713		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000038382	HGNC:12303	NM_007118	Approved	uc003jff.3	NA	D3DTD1|Q13458|Q59EQ7|Q6PJC9|Q6ZN05|Q8IWK8	ENST00000344204.4	37	CCDS3883.1																																																																																			TRIO-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253711.2	7.082837	KEEP		+	16.749168	0.109375	7	57	---	---	---	---	1	1	5	1838	0	167	9	73	0	167	2	0	0	0	0	0	0	9	73	0	167	2	TP
MROH2B	133558	broad.mit.edu	37	5	41049390	41049390	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr5:41049390G>A	ENST00000399564.4	-	14	1943	c.1493C>T	c.(1492-1494)aCa>aTa	p.T498I	MROH2B_ENST00000506092.2_Missense_Mutation_p.T53I	NM_173489.4	NP_775760.3			maestro heat-like repeat family member 2B	NA		NA									NA						ACCAGCTCCTGTAGAGACGAC	0.463	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						86	81	82	NA		NA	NA	5		NA											NA				41049390		1939	4148	6087	SO:0001583	missense			ENSG00000171495	HGNC:26857	NM_173489	Approved		NA		ENST00000399564.4	37	CCDS47202.1	.	.	.	.	.	.	.	.	.	.	G	15.44	2.834027	0.50951	.	.	ENSG00000171495	ENST00000506092;ENST00000296803;ENST00000399564	T;T	0.08458	3.09;3.09	5.18	5.18	0.71444	Armadillo-type fold (1);	0.444772	0.19223	N	0.119640	T	0.10165	0.0249	L	0.38531	1.155	0.33569	D	0.598393	P	0.48503	0.911	P	0.45232	0.474	T	0.12400	-1.0549	10	0.32370	T	0.25	.	14.0617	0.64804	0.0:0.0:1.0:0.0	.	498	Q7Z745	HTRB2_HUMAN	I	53;202;498	ENSP00000441504:T53I;ENSP00000382476:T498I	ENSP00000296803:T202I	T	-	2	0	HEATR7B2	41085147	0.730000	0.28100	1.000000	0.80357	0.973000	0.67179	2.973000	0.49264	2.705000	0.92388	0.650000	0.86243	ACA	MROH2B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367558.2	39.342319	KEEP		-	39.578649	0.608696	14	9	---	---	---	---	0	0	0	0	0	66	70	13	0	66	2	1	1	51	51	0	174	70	13	0	66	2	TP
JMY	133746	broad.mit.edu	37	5	78612055	78612055	+	Silent	SNP	T	T	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr5:78612055T>C	ENST00000396137.4	+	10	3354	c.2892T>C	c.(2890-2892)ctT>ctC	p.L964L	JMY_ENST00000412001.1_Intron	NM_152405.4	NP_689618.4	Q8N9B5	JMY_HUMAN	junction mediating and regulatory protein, p53 cofactor	964		NA			'de novo' actin filament nucleation|actin polymerization-dependent cell motility|Arp2/3 complex-mediated actin nucleation|cell cycle arrest|DNA repair|induction of apoptosis|positive regulation of sequence-specific DNA binding transcription factor activity|regulation of transcription from RNA polymerase II promoter	cell leading edge|cytoplasm|cytoskeleton|nucleus	actin binding|transcription coactivator activity			endometrium(4)|kidney(2)|large_intestine(2)|lung(6)|skin(1)|urinary_tract(1)	16		all_lung(232;0.00051)|Lung NSC(167;0.00131)|Ovarian(174;0.0261)|Prostate(461;0.191)		OV - Ovarian serous cystadenocarcinoma(54;4.45e-45)|Epithelial(54;5.85e-40)|all cancers(79;2.89e-35)		ATGAAGCTCTTAGAAGAATTA	0.438	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						51	48	49	NA		NA	NA	5		NA											NA				78612055		1881	4103	5984	SO:0001819	synonymous_variant			ENSG00000152409	HGNC:28916	NM_152405	Approved	uc003kfx.4	NA	A1L4P5|B5MDS2|B5MDT0	ENST00000396137.4	37	CCDS4047.3																																																																																			JMY-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254070.4	12.395555	KEEP		+	12.823869	0.307692	4	9	---	---	---	---	1	0.9992802	12	21	0	51	7	12	0	51	2	0	0	0	0	0	0	7	12	0	51	2	TP
HOMER1	9456	broad.mit.edu	37	5	78697771	78697771	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr5:78697771T>C	ENST00000334082.6	-	6	2077	c.635A>G	c.(634-636)aAa>aGa	p.K212R	HOMER1_ENST00000508576.1_Intron|HOMER1_ENST00000282260.6_Intron|HOMER1_ENST00000535690.1_Missense_Mutation_p.K38R	NM_004272.3	NP_004263.1	Q86YM7	HOME1_HUMAN	homer homolog 1 (Drosophila)	212		NA			activation of phospholipase C activity by metabotropic glutamate receptor signaling pathway|synaptic transmission	cell junction|integral to plasma membrane|postsynaptic density|postsynaptic membrane				endometrium(2)|kidney(1)|large_intestine(5)|lung(3)|prostate(2)|skin(1)	14		Lung NSC(167;0.00131)|all_lung(232;0.00151)|Ovarian(174;0.0261)|Prostate(461;0.191)		OV - Ovarian serous cystadenocarcinoma(54;1.87e-44)|Epithelial(54;7.07e-41)|all cancers(79;5.5e-36)		AAGTTGCTGTTTCCATTGTTT	0.478	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						169	160	162	NA		NA	NA	5		NA											NA				78697771		1946	4145	6091	SO:0001583	missense			ENSG00000152413	HGNC:17512	NM_004272	Approved	uc003kfy.4	NA	B2R688|O96003|Q86YM5	ENST00000334082.6	37	CCDS43335.1	.	.	.	.	.	.	.	.	.	.	T	18.30	3.594148	0.66219	.	.	ENSG00000152413	ENST00000334082;ENST00000535690	T;T	0.79141	-1.24;-1.24	5.56	5.56	0.83823	.	0.000000	0.85682	D	0.000000	D	0.83862	0.5346	L	0.48642	1.525	0.80722	D	1	D;D	0.67145	0.996;0.99	D;P	0.76071	0.987;0.831	T	0.81994	-0.0677	10	0.30854	T	0.27	-16.6449	15.9986	0.80270	0.0:0.0:0.0:1.0	.	38;212	Q86YM6;Q86YM7	.;HOME1_HUMAN	R	212;38	ENSP00000334382:K212R;ENSP00000441587:K38R	ENSP00000334382:K212R	K	-	2	0	HOMER1	78733527	1.000000	0.71417	1.000000	0.80357	0.988000	0.76386	7.655000	0.83696	2.237000	0.73441	0.533000	0.62120	AAA	HOMER1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000258856.1	324.775734	KEEP		-	324.814189	0.485437	100	106	---	---	---	---	1	1	19	26	0	313	116	128	0	313	2	0	0	0	0	0	0	116	128	0	313	2	TP
APC	324	broad.mit.edu	37	5	112174282	112174282	+	Silent	SNP	T	T	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr5:112174282T>C	ENST00000457016.1	+	16	3371	c.2991T>C	c.(2989-2991)taT>taC	p.Y997Y	APC_ENST00000508376.2_Silent_p.Y997Y|APC_ENST00000257430.4_Silent_p.Y997Y|CTC-554D6.1_ENST00000520401.1_Intron			P25054	APC_HUMAN	adenomatous polyposis coli	997	Responsible for down-regulation through a process mediated by direct ubiquitination.|Ser-rich.	NA			canonical Wnt receptor signaling pathway|cell adhesion|cell cycle arrest|cell migration|cellular component disassembly involved in apoptosis|cytokinesis after mitosis|mitotic cell cycle spindle assembly checkpoint|negative regulation of canonical Wnt receptor signaling pathway|negative regulation of cyclin-dependent protein kinase activity|negative regulation of microtubule depolymerization|positive regulation of apoptosis|positive regulation of cell migration|positive regulation of pseudopodium assembly|protein complex assembly|regulation of attachment of spindle microtubules to kinetochore|response to DNA damage stimulus|tight junction assembly	adherens junction|APC-Axin-1-beta-catenin complex|Axin-APC-beta-catenin-GSK3B complex|beta-catenin destruction complex|centrosome|cytosol|kinetochore|lamellipodium|lateral plasma membrane|nucleus|ruffle membrane|tight junction	beta-catenin binding|gamma-catenin binding|microtubule plus-end binding|protein kinase binding|protein kinase regulator activity	p.?(1)		NS(7)|adrenal_gland(6)|biliary_tract(5)|bone(6)|breast(29)|central_nervous_system(12)|cervix(2)|endometrium(12)|haematopoietic_and_lymphoid_tissue(6)|kidney(8)|large_intestine(2768)|liver(15)|lung(39)|oesophagus(1)|ovary(12)|pancreas(27)|prostate(15)|salivary_gland(2)|skin(14)|small_intestine(34)|soft_tissue(55)|stomach(136)|thyroid(22)|upper_aerodigestive_tract(8)|urinary_tract(20)	3261		all_cancers(142;3.01e-27)|all_epithelial(76;2.3e-18)|all_hematologic(541;4.32e-09)|Ovarian(225;1.78e-06)|Lung NSC(167;0.000195)|Breast(839;0.000231)|all_lung(232;0.000247)|Colorectal(10;0.000355)|Prostate(80;0.00133)		OV - Ovarian serous cystadenocarcinoma(64;1.09e-113)|Epithelial(69;3.79e-112)|all cancers(49;1.67e-104)|BRCA - Breast invasive adenocarcinoma(61;0.00136)|COAD - Colon adenocarcinoma(37;0.00155)|Colorectal(14;0.00191)		TTTGCAGTTATGGTCAATACC	0.343	NA	12	"""D, Mis, N, F, S"""		"""colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS"""	"""colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS"""			Turcot syndrome;Hereditary Desmoid Disease;Familial Adenomatous Polyposis	TSP Lung(16;0.13)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(107;854 1218 9699 17025 28335 47076 52975)|Esophageal Squamous(32;282 584 32991 36563 39392 49665 50115)	yes	Rec	yes	Adenomatous polyposis coli; Turcot syndrome	5	5q21	324	adenomatous polyposis of the colon gene		"""E, M, O"""	1	Unknown(1)	skin(1)	GRCh37	CM010750	APC	M	NA						87	82	84	NA		NA	NA	5		NA											NA				112174282		2202	4300	6502	SO:0001819	synonymous_variant	Familial Cancer Database	Brain tumor-colorectal polyp(osis) syndrome;Familial Infiltrative Mesenteric Fibromatosis;FAP, incl.: Gardner s., Attenuated FAP, Flat Adenoma s., Oldfield s,	ENSG00000134982	HGNC:583	NM_000038	Approved	uc003kpy.4	NA	D3DT03|Q15162|Q15163|Q93042	ENST00000457016.1	37	CCDS4107.1																																																																																			APC-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250738.2	69.750831	KEEP		+	71.010955	0.357143	25	45	---	---	---	---	1	0.9999993	28	30	0	153	27	56	0	153	2	0	0	0	0	0	0	27	56	0	153	2	TP
MAML1	9794	broad.mit.edu	37	5	179201677	179201677	+	Silent	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr5:179201677C>T	ENST00000292599.3	+	5	3113	c.2850C>T	c.(2848-2850)ggC>ggT	p.G950G	MAML1_ENST00000503050.1_Intron	NM_014757.4	NP_055572.1	Q92585	MAML1_HUMAN	mastermind-like 1 (Drosophila)	950		NA			Notch signaling pathway|positive regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent	nuclear speck	peptide antigen binding|protein kinase binding|transcription coactivator activity			central_nervous_system(1)|cervix(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(4)|lung(16)|ovary(2)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)	36	all_cancers(89;0.000197)|all_epithelial(37;6.7e-05)|Renal(175;0.000159)|Lung NSC(126;0.00121)|all_lung(126;0.00218)	all_cancers(40;0.0308)|Medulloblastoma(196;0.00498)|all_neural(177;0.0138)	Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)			CACAGATGGGCGGTCGGGCGG	0.706	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						15	17	17	NA		NA	NA	5		NA											NA				179201677		2198	4292	6490	SO:0001819	synonymous_variant				HGNC:13632	NM_014757	Approved	uc003mkm.3	NA	Q9NZ12	ENST00000292599.3	37	CCDS34315.1																																																																																			MAML1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000372316.2	2.474298	KEEP		+	6.885275	0.125	4	28	---	---	---	---	1	0.9980598	43	53	0	34	5	32	0	34	2	0	0	0	0	0	0	5	32	0	34	2	TP
HIST1H2AC	8334	broad.mit.edu	37	6	26124880	26124880	+	3'UTR	SNP	A	A	G			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr6:26124880A>G	ENST00000377791.2	+	0	508				HIST1H2BC_ENST00000396984.1_5'Flank|HIST1H2AC_ENST00000602637.1_Intron|HIST1H2BC_ENST00000314332.5_5'Flank	NM_003512.3	NP_003503.1	Q93077	H2A1C_HUMAN	histone cluster 1, H2ac	NA		NA			nucleosome assembly	nucleosome|nucleus	DNA binding			NS(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(4)|lung(5)	12						GCTCCCGGAAACGCTATCAAA	0.507	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						39	41	40	NA		NA	NA	6		NA											NA				26124880		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000180573	HGNC:4733	NM_003512	Approved	uc003ngm.3	NA	B2R4F7|O00775|O00776|O00777|O00778|Q540R1	ENST00000377791.2	37	CCDS4585.1																																																																																			HIST1H2AC-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		41.26786	KEEP		+	45.623675	0.235294	16	52	---	---	---	---	1	1	40	196	0	50	16	61	0	50	2	0	0	0	0	0	0	16	61	0	50	2	TP
HIST1H1E	3008	broad.mit.edu	37	6	26156599	26156599	+	5'UTR	SNP	C	C	T	rs2298089		GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr6:26156599C>T	ENST00000304218.3	+	0	41				HIST1H2BD_ENST00000377777.4_5'Flank|HIST1H2BD_ENST00000289316.2_5'Flank	NM_005321.2	NP_005312.1	P10412	H14_HUMAN	histone cluster 1, H1e	NA		NA			nucleosome assembly	nucleosome|nucleus	DNA binding|protein binding			NS(2)|central_nervous_system(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(2)|large_intestine(1)|liver(1)|lung(9)|ovary(2)|prostate(1)|skin(3)|upper_aerodigestive_tract(2)	26						GAATTGCTCTCGCTCACGCTT	0.672	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						36	45	42	NA		NA	NA	6		NA											NA				26156599		2115	4195	6310	SO:0001623	5_prime_UTR_variant			ENSG00000168298	HGNC:4718	NM_005321	Approved	uc003ngq.3	NA	Q4VB25	ENST00000304218.3	37	CCDS4586.1																																																																																			HIST1H1E-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040084.1	10.622065	KEEP		+	11.182357	0.285714	4	10	---	---	---	---	1	0.6071754	2	4	0	129	5	14	0	129	2	0	0	0	0	0	0	5	14	0	129	2	TP
RNF5	6048	broad.mit.edu	37	6	32147882	32147882	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr6:32147882G>A	ENST00000427134.2	+	5	439	c.424G>A	c.(424-426)Gag>Aag	p.E142K	AGPAT1_ENST00000490711.1_5'Flank|AGPAT1_ENST00000336984.6_5'Flank|AGPAT1_ENST00000375104.2_5'Flank|RNF5_ENST00000375094.3_Missense_Mutation_p.E142K|AGPAT1_ENST00000395497.1_5'Flank			Q99942	RNF5_HUMAN	ring finger protein 5, E3 ubiquitin protein ligase	142		NA			ER-associated misfolded protein catabolic process|protein K48-linked ubiquitination|protein K63-linked ubiquitination	endoplasmic reticulum membrane|integral to membrane|mitochondrial membrane	protein binding|ubiquitin-protein ligase activity|zinc ion binding			endometrium(1)|lung(7)|urinary_tract(2)	10						CAATGCCCATGAGCCTTTCCG	0.557	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						141	146	144	NA		NA	NA	6		NA											NA				32147882		1511	2709	4220	SO:0001583	missense				HGNC:10068	NM_006913	Approved	uc031snv.1	NA	A2BFI6|B2R4K3|Q0VDB7|Q9UMQ2	ENST00000427134.2	37		.	.	.	.	.	.	.	.	.	.	G	19.79	3.893301	0.72524	.	.	ENSG00000204308	ENST00000375094;ENST00000427134	D;D	0.94000	-3.33;-3.33	5.36	5.36	0.76844	.	0.253964	0.38272	N	0.001748	D	0.92938	0.7753	L	0.46157	1.445	0.38768	D	0.95447	P	0.47910	0.902	P	0.55455	0.776	D	0.92332	0.5874	10	0.40728	T	0.16	-6.1743	16.9524	0.86249	0.0:0.0:1.0:0.0	.	142	Q99942	RNF5_HUMAN	K	142	ENSP00000364235:E142K;ENSP00000407656:E142K	ENSP00000364235:E142K	E	+	1	0	RNF5	32255860	1.000000	0.71417	0.949000	0.38748	0.993000	0.82548	5.427000	0.66483	2.666000	0.90696	0.655000	0.94253	GAG	RNF5-201	KNOWN	basic	protein_coding	NA	protein_coding		685.600978	KEEP		+	685.829079	0.52506	220	199	---	---	---	---	1	1	153	272	0	266	286	247	0	266	2	0	0	0	0	0	0	286	247	0	266	2	TP
COL11A2	1302	broad.mit.edu	37	6	33133402	33133402	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr6:33133402C>A	ENST00000341947.2	-	63	4901	c.4674G>T	c.(4672-4674)agG>agT	p.R1558S	COL11A2_ENST00000357486.1_Missense_Mutation_p.R1537S|COL11A2_ENST00000374713.1_Missense_Mutation_p.R1511S|COL11A2_ENST00000374712.1_Missense_Mutation_p.R1477S|COL11A2_ENST00000477772.1_5'UTR|COL11A2_ENST00000374708.4_Missense_Mutation_p.R1472S|COL11A2_ENST00000361917.1_Missense_Mutation_p.R1451S|COL11A2_ENST00000374714.1_Missense_Mutation_p.R1532S|COL11A2_ENST00000395197.1_Missense_Mutation_p.R1498S	NM_080680.2	NP_542411.2	P13942	COBA2_HUMAN	collagen, type XI, alpha 2	1558	Fibrillar collagen NC1.	NA			cartilage development|cell adhesion|collagen fibril organization|sensory perception of sound|soft palate development	collagen type XI	extracellular matrix structural constituent conferring tensile strength|protein binding, bridging			biliary_tract(1)|breast(1)|cervix(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(13)|liver(1)|lung(27)|ovary(5)|prostate(5)|skin(6)	68						CTGTTGGCCGCCTCATCTGCT	0.662	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(1;90 116 3946 5341 17093)							NA				0							NA						63	63	63	NA		NA	NA	6		NA											NA				33133402		2203	4300	6503	SO:0001583	missense			ENSG00000204248	HGNC:2187		Approved	uc003ocx.1	NA	Q07751|Q13271|Q13272|Q13273|Q5JP94|Q5SUI8|Q99866|Q9UIP9	ENST00000341947.2	37		.	.	.	.	.	.	.	.	.	.	C	14.04	2.416286	0.42918	.	.	ENSG00000204248	ENST00000374708;ENST00000341947;ENST00000357486;ENST00000374714;ENST00000374713;ENST00000395197;ENST00000374712;ENST00000361917;ENST00000395196	T;T;T;T;T;T;T;T	0.74526	-0.85;-0.85;-0.85;-0.85;-0.85;-0.85;-0.85;-0.85	4.4	3.54	0.40534	Fibrillar collagen, C-terminal (3);	0.000000	0.85682	D	0.000000	T	0.81098	0.4752	M	0.88105	2.93	0.53005	D	0.999966	P;D;D;D	0.56287	0.954;0.969;0.969;0.975	P;P;P;P	0.60012	0.867;0.723;0.723;0.819	D	0.84016	0.0351	10	0.87932	D	0	.	10.0846	0.42410	0.0:0.9016:0.0:0.0984	.	154;1451;1472;1558	A2ABA7;P13942-8;P13942-6;P13942	.;.;.;COBA2_HUMAN	S	1472;1558;1537;1532;1511;1498;1477;1451;128	ENSP00000363840:R1472S;ENSP00000339915:R1558S;ENSP00000350079:R1537S;ENSP00000363846:R1532S;ENSP00000363845:R1511S;ENSP00000378623:R1498S;ENSP00000363844:R1477S;ENSP00000355123:R1451S	ENSP00000339915:R1558S	R	-	3	2	COL11A2	33241380	1.000000	0.71417	1.000000	0.80357	0.921000	0.55340	0.899000	0.28417	1.082000	0.41137	-0.271000	0.10264	AGG	COL11A2-201	KNOWN	basic	protein_coding	NA	protein_coding		33.071513	KEEP		-	34.026226	0.333333	13	26	---	---	---	---	1	0.9999949	30	24	0	148	15	28	0	148	2	0	0	0	0	0	0	15	28	0	148	2	TP
CRIP3	401262	broad.mit.edu	37	6	43273549	43273549	+	3'UTR	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr6:43273549G>A	ENST00000372569.3	-	0	622				ZNF318_ENST00000607252.1_5'Flank	NM_206922.2	NP_996805.2	Q6Q6R5	CRIP3_HUMAN	cysteine-rich protein 3	NA		NA				cytoplasm	zinc ion binding			endometrium(1)|kidney(1)|large_intestine(1)|lung(4)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	10			Colorectal(64;0.00245)|COAD - Colon adenocarcinoma(64;0.00536)|all cancers(41;0.00998)|OV - Ovarian serous cystadenocarcinoma(102;0.0305)			TTTTGTGAGCGTCTCATTTGA	0.507	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA	G		0,4174		0,0,2087	103	108	106	NA		-8.9	0	6		106	2,8466		0,2,4232	no	utr-3	CRIP3	NM_206922.2		0,2,6319	AA,AG,GG	NA	0.0236,0.0,0.0158			43273549	2,12640	2087	4234	6321	SO:0001624	3_prime_UTR_variant			ENSG00000146215	HGNC:17751		Approved	uc003ouu.1	NA	A2A436|Q5T043|Q6Q6R4|Q6Q6R6|Q6Q6R7	ENST00000372569.3	37	CCDS4894.2																																																																																			CRIP3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040594.1	-33.936533	KEEP		-	13.644429	0.034653	7	195	---	---	---	---	1	0.1981298	10	12	0	175	9	259	0	175	2	0	0	0	0	0	0	9	259	0	175	2	TP
MAP3K7	6885	broad.mit.edu	37	6	91254301	91254301	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr6:91254301T>C	ENST00000369329.3	-	12	1422	c.1261A>G	c.(1261-1263)Att>Gtt	p.I421V	MAP3K7_ENST00000369325.3_Missense_Mutation_p.I421V|MAP3K7_ENST00000369320.1_Intron|MAP3K7_ENST00000369332.3_Intron|MAP3K7_ENST00000369327.3_Intron	NM_145331.2	NP_663304.1	O43318	M3K7_HUMAN	mitogen-activated protein kinase kinase kinase 7	421		NA			activation of MAPK activity|activation of NF-kappaB-inducing kinase activity|histone H3 acetylation|I-kappaB phosphorylation|innate immune response|JNK cascade|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of interleukin-2 production|positive regulation of JUN kinase activity|positive regulation of NF-kappaB transcription factor activity|positive regulation of T cell cytokine production|stress-activated MAPK cascade|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|transforming growth factor beta receptor signaling pathway	Ada2/Gcn5/Ada3 transcription activator complex|cytosol|endosome membrane	ATP binding|magnesium ion binding|MAP kinase kinase kinase activity|protein binding			endometrium(4)|kidney(1)|large_intestine(5)|lung(10)|ovary(3)|skin(2)|stomach(1)|upper_aerodigestive_tract(2)	28		all_cancers(76;6.4e-08)|Acute lymphoblastic leukemia(125;1.43e-09)|Prostate(29;9.32e-09)|all_hematologic(105;3.69e-06)|all_epithelial(107;0.000187)|Ovarian(999;0.0164)		OV - Ovarian serous cystadenocarcinoma(136;2.05e-11)|all cancers(137;3.25e-11)|GBM - Glioblastoma multiforme(226;0.0416)|BRCA - Breast invasive adenocarcinoma(108;0.0429)		ACATCCAGAATGTTGCCAAAT	0.418	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						135	127	130	NA		NA	NA	6		NA											NA				91254301		2203	4300	6503	SO:0001583	missense			ENSG00000135341	HGNC:6859	NM_145331	Approved	uc003pnz.2	NA	B2RE27|E1P523|O43317|O43319|Q5TDN2|Q5TDN3|Q5TDT7	ENST00000369329.3	37	CCDS5028.1	.	.	.	.	.	.	.	.	.	.	T	25.8	4.673270	0.88445	.	.	ENSG00000135341	ENST00000369329;ENST00000369325	T;T	0.77229	-1.03;-1.08	5.47	5.47	0.80525	.	0.092333	0.64402	D	0.000001	T	0.77219	0.4098	L	0.43152	1.355	0.80722	D	1	D;P	0.56968	0.978;0.518	D;P	0.70227	0.968;0.456	T	0.74469	-0.3655	10	0.18710	T	0.47	.	15.5475	0.76118	0.0:0.0:0.0:1.0	.	421;421	O43318-3;O43318	.;M3K7_HUMAN	V	421	ENSP00000358335:I421V;ENSP00000358331:I421V	ENSP00000358331:I421V	I	-	1	0	MAP3K7	91311022	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	7.698000	0.84413	2.082000	0.62665	0.402000	0.26972	ATT	MAP3K7-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041530.1	258.439382	KEEP		-	259.376601	0.589552	79	55	---	---	---	---	1	1	80	59	0	162	104	74	0	162	2	0	0	0	0	0	0	104	74	0	162	2	TP
VPS41	27072	broad.mit.edu	37	7	38816326	38816326	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr7:38816326C>T	ENST00000310301.4	-	11	889	c.835G>A	c.(835-837)Gat>Aat	p.D279N	VPS41_ENST00000395969.2_Missense_Mutation_p.D254N|VPS41_ENST00000466017.1_5'UTR	NM_014396.3	NP_055211.2	P49754	VPS41_HUMAN	vacuolar protein sorting 41 homolog (S. cerevisiae)	279		NA			Golgi vesicle transport|intracellular protein transport|vesicle-mediated transport	cytosol|Golgi-associated vesicle|HOPS complex|membrane fraction	zinc ion binding			NS(1)|breast(1)|central_nervous_system(2)|endometrium(5)|kidney(4)|large_intestine(5)|lung(17)|ovary(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(4)	44						ACAAGCTGATCACAGAGAGGT	0.413	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						94	83	87	NA		NA	NA	7		NA											NA				38816326		2203	4300	6503	SO:0001583	missense			ENSG00000006715	HGNC:12713		Approved	uc003tgy.3	NA	Q86TP8|Q99851|Q99852	ENST00000310301.4	37	CCDS5457.1	.	.	.	.	.	.	.	.	.	.	C	17.06	3.292452	0.59976	.	.	ENSG00000006715	ENST00000310301;ENST00000395969	T;T	0.39592	1.07;1.07	6.06	6.06	0.98353	.	0.000000	0.85682	D	0.000000	T	0.36358	0.0964	L	0.39020	1.185	0.80722	D	1	B;B;B	0.33549	0.417;0.417;0.417	B;B;B	0.28553	0.091;0.091;0.091	T	0.05852	-1.0860	10	0.30078	T	0.28	-30.7415	20.6208	0.99490	0.0:1.0:0.0:0.0	.	279;254;279	B2RB94;E9PF36;P49754	.;.;VPS41_HUMAN	N	279;254	ENSP00000309457:D279N;ENSP00000379297:D254N	ENSP00000309457:D279N	D	-	1	0	VPS41	38782851	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	7.487000	0.81328	2.882000	0.98803	0.655000	0.94253	GAT	VPS41-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000226986.3	129.137511	KEEP		-	129.919909	0.619048	39	24	---	---	---	---	1	1	37	115	0	72	50	36	0	72	2	0	0	0	0	0	0	50	36	0	72	2	TP
DUS4L	11062	broad.mit.edu	37	7	107217955	107217955	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr7:107217955T>G	ENST00000265720.3	+	8	1266	c.904T>G	c.(904-906)Tca>Gca	p.S302A	BCAP29_ENST00000465919.1_5'Flank|DUS4L_ENST00000402620.1_Missense_Mutation_p.S181A|BCAP29_ENST00000379117.2_5'Flank|BCAP29_ENST00000445771.2_5'Flank|BCAP29_ENST00000005259.4_5'Flank	NM_001270419.1|NM_181581.2	NP_001257348.1|NP_853559.1	O95620	DUS4L_HUMAN	dihydrouridine synthase 4-like (S. cerevisiae)	302		NA			tRNA processing		flavin adenine dinucleotide binding|tRNA dihydrouridine synthase activity			breast(1)|endometrium(1)|large_intestine(2)|lung(2)|skin(1)|stomach(1)	8						TAATGCTCTGTCAAGCACATC	0.353	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						126	132	130	NA		NA	NA	7		NA											NA				107217955		2203	4300	6503	SO:0001583	missense			ENSG00000105865	HGNC:21517	NM_181581	Approved	uc031syv.1	NA	B4DLX0|Q2NKK1	ENST00000265720.3	37	CCDS5745.1	.	.	.	.	.	.	.	.	.	.	T	19.24	3.788539	0.70337	.	.	ENSG00000105865	ENST00000265720;ENST00000402620	T;T	0.22945	1.93;1.93	5.67	5.67	0.87782	.	0.000000	0.85682	D	0.000000	T	0.27967	0.0689	L	0.53561	1.675	0.58432	D	0.999999	B;B	0.26318	0.146;0.146	B;B	0.29077	0.098;0.098	T	0.04454	-1.0950	10	0.20519	T	0.43	.	16.215	0.82206	0.0:0.0:0.0:1.0	.	302;302	A4D0R5;O95620	.;DUS4L_HUMAN	A	302;181	ENSP00000265720:S302A;ENSP00000385274:S181A	ENSP00000265720:S302A	S	+	1	0	DUS4L	107005191	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	7.563000	0.82314	2.288000	0.76882	0.533000	0.62120	TCA	DUS4L-007	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336967.2	30.40868	KEEP		+	32.073118	0.282051	11	28	---	---	---	---	1	0.9999854	23	42	0	134	13	33	0	134	2	0	0	0	0	0	0	13	33	0	134	2	TP
AGAP3	116988	broad.mit.edu	37	7	150840450	150840450	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr7:150840450C>T	ENST00000397238.2	+	17	2296	c.2296C>T	c.(2296-2298)Cgg>Tgg	p.R766W	AGAP3_ENST00000463381.1_Missense_Mutation_p.R435W	NM_031946.4	NP_114152.3	Q96P47	AGAP3_HUMAN	ArfGAP with GTPase domain, ankyrin repeat and PH domain 3	730		NA			regulation of ARF GTPase activity|small GTPase mediated signal transduction	cytoplasm|membrane	ARF GTPase activator activity|GTP binding|GTPase activity|zinc ion binding			central_nervous_system(2)|endometrium(3)|kidney(3)|large_intestine(3)|liver(2)|lung(9)|ovary(2)|prostate(3)|urinary_tract(1)	28						ACGCTGGATACGGGCCAAGTA	0.622	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						49	56	53	NA		NA	NA	7		NA											NA				150840450		2119	4246	6365	SO:0001583	missense			ENSG00000133612	HGNC:16923	NM_031946	Approved	uc003wjg.1	NA	Q59EN0|Q96RK3	ENST00000397238.2	37	CCDS43681.1	.	.	.	.	.	.	.	.	.	.	C	19.38	3.816242	0.70912	.	.	ENSG00000133612	ENST00000463381;ENST00000397232;ENST00000397238;ENST00000335355	T;T	0.50548	0.74;0.74	5.28	3.4	0.38934	.	0.068783	0.64402	D	0.000013	T	0.77478	0.4136	H	0.98027	4.13	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;1.0;1.0	D;D;D;D	0.97110	1.0;0.993;0.99;0.975	T	0.82878	-0.0239	10	0.87932	D	0	.	9.7714	0.40591	0.1385:0.788:0.0:0.0735	.	730;265;766;435	Q96P47;E7ETI2;Q96P47-4;B3KNZ8	AGAP3_HUMAN;.;.;.	W	435;265;766;730	ENSP00000418016:R435W;ENSP00000380413:R766W	ENSP00000334157:R730W	R	+	1	2	AGAP3	150471383	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	3.716000	0.54904	1.458000	0.47871	0.655000	0.94253	CGG	AGAP3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000351908.3	284.553549	KEEP		+	285.921939	0.604167	87	57	---	---	---	---	1	1	97	224	0	88	110	73	0	88	2	0	0	0	0	0	0	110	73	0	88	2	TP
HSPA5	3309	broad.mit.edu	37	9	128000495	128000495	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr9:128000495C>T	ENST00000324460.6	-	7	1530	c.1327G>A	c.(1327-1329)Gtg>Atg	p.V443M		NM_005347.4	NP_005338.1	P11021	GRP78_HUMAN	heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	443		NA			anti-apoptosis|cellular response to glucose starvation|ER-associated protein catabolic process|platelet activation|platelet degranulation|regulation of protein folding in endoplasmic reticulum	cell surface|endoplasmic reticulum chaperone complex|endoplasmic reticulum lumen|ER-Golgi intermediate compartment|integral to endoplasmic reticulum membrane|melanosome|midbody|nucleus|perinuclear region of cytoplasm	ATP binding|ATPase activity|calcium ion binding|caspase inhibitor activity|chaperone binding|misfolded protein binding|protein binding, bridging|protein domain specific binding|ubiquitin protein ligase binding|unfolded protein binding			breast(1)|endometrium(2)|kidney(2)|large_intestine(2)|lung(9)|ovary(4)|prostate(2)|skin(1)	23					Antihemophilic Factor(DB00025)	TTGGTAGGCACCACTGTGTTC	0.408	NA	NA								Prostate(1;0.17)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						142	131	135	NA		NA	NA	9		NA											NA				128000495		2203	4300	6503	SO:0001583	missense			ENSG00000044574	HGNC:5238		Approved	uc004bpn.3	NA	B0QZ61|Q2EF78|Q9NPF1|Q9UK02	ENST00000324460.6	37	CCDS6863.1	.	.	.	.	.	.	.	.	.	.	C	26.9	4.782071	0.90282	.	.	ENSG00000044574	ENST00000324460	T	0.05319	3.46	4.61	4.61	0.57282	.	0.000000	0.85682	D	0.000000	T	0.31949	0.0813	M	0.90870	3.155	0.80722	D	1	P	0.50528	0.936	D	0.64410	0.925	T	0.40059	-0.9583	10	0.87932	D	0	-10.2673	16.4354	0.83873	0.0:1.0:0.0:0.0	.	443	P11021	GRP78_HUMAN	M	443	ENSP00000324173:V443M	ENSP00000324173:V443M	V	-	1	0	HSPA5	127040316	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	6.079000	0.71291	2.092000	0.63282	0.557000	0.71058	GTG	HSPA5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054062.1	-32.460107	KEEP		-	14.8427	0.038835	8	198	---	---	---	---	1	1	2	2192	0	226	9	249	0	226	2	0	0	0	0	0	0	9	249	0	226	2	TP
KIAA1462	57608	broad.mit.edu	37	10	30315264	30315264	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr10:30315264C>T	ENST00000375377.1	-	3	3914	c.3813G>A	c.(3811-3813)atG>atA	p.M1271I		NM_020848.2	NP_065899.1	Q9P266	K1462_HUMAN	KIAA1462	1271		NA								breast(3)|endometrium(11)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(17)|lung(23)|ovary(6)|prostate(3)|skin(5)|upper_aerodigestive_tract(1)	75						TCAGGACTCTCATCCGTGACA	0.582	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						52	51	51	NA		NA	NA	10		NA											NA				30315264		1962	4140	6102	SO:0001583	missense			ENSG00000165757	HGNC:29283	NM_020848	Approved	uc001iux.3	NA	Q5HYA7|Q5T992|Q86WZ9|Q9BYJ2	ENST00000375377.1	37	CCDS41500.1	.	.	.	.	.	.	.	.	.	.	C	15.57	2.873427	0.51695	.	.	ENSG00000165757	ENST00000375377	T	0.14766	2.48	5.44	4.45	0.53987	.	0.042841	0.85682	D	0.000000	T	0.23492	0.0568	M	0.70275	2.135	0.46011	D	0.998811	P	0.50528	0.936	P	0.46320	0.512	T	0.02950	-1.1090	10	0.44086	T	0.13	-25.8983	16.8782	0.86057	0.137:0.863:0.0:0.0	.	1271	Q9P266	K1462_HUMAN	I	1271	ENSP00000364526:M1271I	ENSP00000364526:M1271I	M	-	3	0	KIAA1462	30355270	1.000000	0.71417	0.972000	0.41901	0.090000	0.18270	2.572000	0.45999	2.557000	0.86248	0.655000	0.94253	ATG	KIAA1462-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000047409.1	32.682494	KEEP		-	33.449213	0.342857	12	23	---	---	---	---	1	0.990473	5	13	0	145	16	29	0	145	2	0	0	0	0	0	0	16	29	0	145	2	TP
RCN1	5954	broad.mit.edu	37	11	32119964	32119964	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr11:32119964A>G	ENST00000054950.3	+	3	810	c.517A>G	c.(517-519)Aga>Gga	p.R173G	RP1-65P5.3_ENST00000533009.1_RNA|RCN1_ENST00000532942.1_Missense_Mutation_p.R122G	NM_002901.2	NP_002892.1	Q15293	RCN1_HUMAN	reticulocalbin 1, EF-hand calcium binding domain	173	EF-hand 3.	NA				endoplasmic reticulum lumen	calcium ion binding			breast(2)|endometrium(2)|kidney(2)|large_intestine(5)|lung(6)	17	Lung SC(675;0.225)					ACGTGATGAGAGAAGATTCAA	0.433	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						76	71	73	NA		NA	NA	11		NA											NA				32119964		2202	4297	6499	SO:0001583	missense			ENSG00000049449	HGNC:9934	NM_002901	Approved	uc010reb.2	NA	D3DR00	ENST00000054950.3	37	CCDS7876.1	.	.	.	.	.	.	.	.	.	.	a	19.15	3.771893	0.69992	.	.	ENSG00000049449	ENST00000530348;ENST00000532942;ENST00000054950;ENST00000532721	T;T;T	0.73469	0.56;-0.75;-0.75	5.45	5.45	0.79879	EF-hand-like domain (1);	0.000000	0.85682	D	0.000000	D	0.88522	0.6459	M	0.89785	3.06	0.80722	D	1	D;D	0.89917	0.998;1.0	D;D	0.97110	0.993;1.0	D	0.90638	0.4572	10	0.62326	D	0.03	-18.1406	15.5271	0.75919	1.0:0.0:0.0:0.0	.	173;122	Q15293;B7Z1M1	RCN1_HUMAN;.	G	7;122;173;7	ENSP00000436482:R7G;ENSP00000436422:R122G;ENSP00000054950:R173G	ENSP00000054950:R173G	R	+	1	2	RCN1	32076540	1.000000	0.71417	1.000000	0.80357	0.734000	0.41952	4.777000	0.62361	2.078000	0.62432	0.482000	0.46254	AGA	RCN1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000388510.1	433.60726	KEEP		+	438.617119	0.673797	126	61	---	---	---	---	1	1	234	123	0	97	145	70	0	97	2	0	0	0	0	0	0	145	70	0	97	2	TP
AHNAK	79026	broad.mit.edu	37	11	62294227	62294227	+	Silent	SNP	A	A	G			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr11:62294227A>G	ENST00000378024.4	-	5	7936	c.7662T>C	c.(7660-7662)aaT>aaC	p.N2554N	AHNAK_ENST00000530124.1_Intron|AHNAK_ENST00000257247.7_Intron	NM_001620.1	NP_001611.1	Q09666	AHNK_HUMAN	AHNAK nucleoprotein	2554		NA			nervous system development	nucleus	protein binding			NS(3)|autonomic_ganglia(1)|breast(10)|central_nervous_system(5)|endometrium(17)|haematopoietic_and_lymphoid_tissue(2)|kidney(33)|large_intestine(40)|liver(1)|lung(108)|ovary(13)|pancreas(4)|prostate(5)|skin(16)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(6)	268		Melanoma(852;0.155)				GTCCTTCAATATTAACATCAG	0.483	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						142	145	144	NA		NA	NA	11		NA											NA				62294227		2202	4299	6501	SO:0001819	synonymous_variant			ENSG00000124942	HGNC:347	NM_024060	Approved	uc001ntl.3	NA		ENST00000378024.4	37	CCDS31584.1																																																																																			AHNAK-005	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000395572.1	12.326836	KEEP		-	16.566049	0.157895	6	32	---	---	---	---	1	0.1453102	2	2	0	275	6	33	0	275	2	0	0	0	0	0	0	6	33	0	275	2	TP
CCDC15	80071	broad.mit.edu	37	11	124857652	124857652	+	Silent	SNP	G	G	A	rs111966038		GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr11:124857652G>A	ENST00000529051.1	+	8	1789	c.1530G>A	c.(1528-1530)ttG>ttA	p.L510L	CCDC15_ENST00000344762.5_Silent_p.L510L			Q0P6D6	CCD15_HUMAN	coiled-coil domain containing 15	510		NA				centrosome				central_nervous_system(1)|cervix(1)|large_intestine(6)|lung(10)|ovary(1)|prostate(3)|skin(1)	23	all_hematologic(175;0.215)	Breast(109;0.00222)|Lung NSC(97;0.0177)|all_lung(97;0.0179)|Medulloblastoma(222;0.0425)|all_neural(223;0.112)		BRCA - Breast invasive adenocarcinoma(274;1.68e-06)|OV - Ovarian serous cystadenocarcinoma(99;0.0413)		AGAATTTTTTGTCTAGAGACC	0.388	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						148	141	144	NA		NA	NA	11		NA											NA				124857652		1808	4073	5881	SO:0001819	synonymous_variant			ENSG00000149548	HGNC:25798	NM_025004	Approved	uc001qbm.4	NA	Q9H8U7	ENST00000529051.1	37																																																																																				CCDC15-002	NOVEL	basic	protein_coding	NA	protein_coding	OTTHUMT00000387130.1	-6.025682	KEEP		+	6.307185	0.051724	3	55	---	---	---	---	1	0.1466482	3	13	1	318	2	70	1	318	2	0	0	0	0	0	0	2	70	1	318	2	TP
CREBL2	1389	broad.mit.edu	37	12	12765120	12765120	+	Splice_Site	SNP	A	A	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr12:12765120A>C	ENST00000228865.2	+	1	295	c.15_splice	c.e1+1	p.K5_splice	CREBL2_ENST00000540224.1_3'UTR	NM_001310.2	NP_001301.1	O60519	CRBL2_HUMAN	cAMP responsive element binding protein-like 2	5		NA			cell cycle|signal transduction	nucleus	protein dimerization activity|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity			large_intestine(1)	1		Prostate(47;0.0684)		BRCA - Breast invasive adenocarcinoma(232;0.0503)		GATGACAGTAAGGTAAGTCTT	0.677	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						86	83	84	NA		NA	NA	12		NA											NA				12765120		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000111269	HGNC:2350	NM_001310	Approved	uc001rap.1	NA	B5BUM5	ENST00000228865.2	37	CCDS8651.1	.	.	.	.	.	.	.	.	.	.	A	24.4	4.529265	0.85706	.	.	ENSG00000111269	ENST00000228865	.	.	.	5.23	5.23	0.72850	.	0.144057	0.64402	D	0.000007	T	0.38134	0.1029	N	0.22421	0.69	0.31980	N	0.606053	P	0.51653	0.947	P	0.53490	0.727	T	0.47598	-0.9105	9	0.44086	T	0.13	-18.3905	7.6523	0.28354	0.9082:0.0:0.0918:0.0	.	5	O60519	CRBL2_HUMAN	T	5	.	ENSP00000228865:K5T	K	+	2	0	CREBL2	12656387	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	4.333000	0.59285	2.184000	0.69523	0.533000	0.62120	AAG	CREBL2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400660.1	155.758542	KEEP	Missense_Mutation	+	156.519113	0.60241	50	33	---	---	---	---	1	1	20	42	0	128	77	44	0	128	2	0	0	0	0	0	0	77	44	0	128	2	TP
CNTN1	1272	broad.mit.edu	37	12	41410534	41410534	+	Silent	SNP	A	A	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr12:41410534A>T	ENST00000551295.2	+	19	2352	c.2235A>T	c.(2233-2235)gcA>gcT	p.A745A	CNTN1_ENST00000347616.1_Silent_p.A745A|CNTN1_ENST00000550305.1_3'UTR|CNTN1_ENST00000348761.2_Silent_p.A734A	NM_001843.3	NP_001834.2	Q12860	CNTN1_HUMAN	contactin 1	745	Fibronectin type-III 2.	NA			axon guidance|cell adhesion|Notch signaling pathway	anchored to membrane|membrane fraction|plasma membrane				central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(1)|large_intestine(21)|lung(49)|ovary(3)|prostate(2)|skin(4)|upper_aerodigestive_tract(3)|urinary_tract(2)	90	all_cancers(12;2.07e-06)|all_epithelial(1;4.26e-06)|Breast(8;0.0716)	Lung NSC(34;0.0211)|all_lung(34;0.0294)				ACATAGTGGCATTTAAGCCAT	0.368	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						95	85	88	NA		NA	NA	12		NA											NA				41410534		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:2171	NM_001843	Approved	uc031qgz.1	NA	A8K0H9|A8K0Y3|Q12861|Q14030|Q7M4P0|Q8N466	ENST00000551295.2	37	CCDS8737.1																																																																																			CNTN1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000403692.2	65.301633	KEEP		+	65.354403	0.540541	20	17	---	---	---	---	1	1	91	191	0	161	24	23	0	161	2	0	0	0	0	0	0	24	23	0	161	2	TP
SRGAP1	57522	broad.mit.edu	37	12	64491111	64491111	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr12:64491111C>T	ENST00000355086.3	+	15	2293	c.1769C>T	c.(1768-1770)cCc>cTc	p.P590L	SRGAP1_ENST00000357825.3_Missense_Mutation_p.P567L|RP11-196H14.2_ENST00000535594.1_RNA|SRGAP1_ENST00000543397.1_Missense_Mutation_p.P527L	NM_020762.2	NP_065813.1	Q7Z6B7	SRGP1_HUMAN	SLIT-ROBO Rho GTPase activating protein 1	590	Rho-GAP.	NA			axon guidance	cytosol				breast(4)|central_nervous_system(3)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(11)|lung(26)|ovary(2)|prostate(3)|skin(2)|upper_aerodigestive_tract(1)	65			GBM - Glioblastoma multiforme(3;0.000139)|BRCA - Breast invasive adenocarcinoma(9;0.225)	GBM - Glioblastoma multiforme(28;0.0608)		CTGGAAAACCCCCTCTTTCCT	0.378	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						93	91	92	NA		NA	NA	12		NA											NA				64491111		2203	4300	6503	SO:0001583	missense			ENSG00000196935	HGNC:17382		Approved	uc010ssp.1	NA	Q9H8A3|Q9P2P2	ENST00000355086.3	37	CCDS8967.1	.	.	.	.	.	.	.	.	.	.	C	33	5.247279	0.95305	.	.	ENSG00000196935	ENST00000355086;ENST00000357825;ENST00000543397	T;T;T	0.58358	0.34;0.34;0.34	5.53	5.53	0.82687	Rho GTPase-activating protein domain (4);Rho GTPase activation protein (1);	0.000000	0.35013	U	0.003518	T	0.82263	0.4999	H	0.96460	3.825	0.80722	D	1	D;D	0.76494	0.999;0.999	D;D	0.74023	0.976;0.982	D	0.87448	0.2399	9	.	.	.	.	19.8385	0.96670	0.0:1.0:0.0:0.0	.	590;527	Q7Z6B7;G5EA48	SRGP1_HUMAN;.	L	590;567;527	ENSP00000347198:P590L;ENSP00000350480:P567L;ENSP00000437948:P527L	.	P	+	2	0	SRGAP1	62777378	1.000000	0.71417	1.000000	0.80357	1.000000	0.99986	7.726000	0.84824	2.761000	0.94854	0.655000	0.94253	CCC	SRGAP1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400896.1	3.204418	KEEP		+	7.743687	0.103448	3	26	---	---	---	---	1	0.5589181	10	4	0	145	4	30	0	145	2	0	0	0	0	0	0	4	30	0	145	2	TP
ZNF664	144348	broad.mit.edu	37	12	124497249	124497249	+	Silent	SNP	C	C	G	rs149546232		GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr12:124497249C>G	ENST00000539644.1	+	6	2388	c.558C>G	c.(556-558)ctC>ctG	p.L186L	ZNF664_ENST00000337815.4_Silent_p.L186L|RP11-522N14.1_ENST00000540762.1_RNA|ZNF664_ENST00000538932.2_Silent_p.L186L|ZNF664_ENST00000392404.3_Silent_p.L186L			Q8N3J9	ZN664_HUMAN	zinc finger protein 664	186		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|large_intestine(5)|lung(6)|skin(1)	13	all_neural(191;0.101)|Medulloblastoma(191;0.163)			Epithelial(86;0.000239)|OV - Ovarian serous cystadenocarcinoma(86;0.000247)|all cancers(50;0.00155)|BRCA - Breast invasive adenocarcinoma(302;0.249)		GTTCGAGCCTCTGCATCCACC	0.522	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						107	104	105	NA		NA	NA	12		NA											NA				124497249		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000179195	HGNC:25406	NM_152437	Approved	uc001uga.3	NA	B3KP97|Q15914|Q3ZCQ7	ENST00000539644.1	37	CCDS9257.1																																																																																			ZNF664-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400365.1	-9.463965	KEEP		+	8.274377	0.04878	4	78	---	---	---	---	1	0.9999781	20	424	0	152	7	109	0	152	2	0	0	0	0	0	0	7	109	0	152	2	TP
ZNF664	144348	broad.mit.edu	37	12	124497273	124497273	+	Silent	SNP	T	T	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr12:124497273T>A	ENST00000539644.1	+	6	2412	c.582T>A	c.(580-582)acT>acA	p.T194T	ZNF664_ENST00000337815.4_Silent_p.T194T|RP11-522N14.1_ENST00000540762.1_RNA|ZNF664_ENST00000538932.2_Silent_p.T194T|ZNF664_ENST00000392404.3_Silent_p.T194T			Q8N3J9	ZN664_HUMAN	zinc finger protein 664	194		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|large_intestine(5)|lung(6)|skin(1)	13	all_neural(191;0.101)|Medulloblastoma(191;0.163)			Epithelial(86;0.000239)|OV - Ovarian serous cystadenocarcinoma(86;0.000247)|all cancers(50;0.00155)|BRCA - Breast invasive adenocarcinoma(302;0.249)		GAGTCCACACTGGAGAGAAAC	0.498	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						105	103	104	NA		NA	NA	12		NA											NA				124497273		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000179195	HGNC:25406	NM_152437	Approved	uc001uga.3	NA	B3KP97|Q15914|Q3ZCQ7	ENST00000539644.1	37	CCDS9257.1																																																																																			ZNF664-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400365.1	-15.36618	KEEP		+	7.149886	0.040404	4	95	---	---	---	---	1	0.9993231	9	427	0	157	5	122	0	157	2	0	0	0	0	0	0	5	122	0	157	2	TP
RNASEH2B	79621	broad.mit.edu	37	13	51530575	51530575	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr13:51530575G>C	ENST00000336617.3	+	11	1303	c.904G>C	c.(904-906)Ggg>Cgg	p.G302R	RNASEH2B_ENST00000422660.1_Intron|RNASEH2B_ENST00000495244.2_3'UTR	NM_024570.3	NP_078846.2	Q5TBB1	RNH2B_HUMAN	ribonuclease H2, subunit B	302		NA			RNA catabolic process	nucleus|ribonuclease H2 complex				endometrium(2)|liver(1)|lung(1)|upper_aerodigestive_tract(1)	5		Acute lymphoblastic leukemia(7;1.03e-07)|Breast(56;0.00122)|Lung NSC(96;0.00143)|Prostate(109;0.0047)|Hepatocellular(98;0.152)|Glioma(44;0.236)		GBM - Glioblastoma multiforme(99;9e-08)		TACCTTTTTTGGGGTAAAAAA	0.299	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						23	26	25	NA		NA	NA	13		NA											NA				51530575		2196	4289	6485	SO:0001583	missense			ENSG00000136104	HGNC:25671	NM_024570	Approved	uc001vfa.4	NA	Q6PK48|Q9HAF7	ENST00000336617.3	37	CCDS9425.1	.	.	.	.	.	.	.	.	.	.	G	11.28	1.591563	0.28357	.	.	ENSG00000136104	ENST00000336617;ENST00000539292	D	0.96774	-4.12	6.06	6.06	0.98353	.	0.335255	0.38326	N	0.001723	D	0.93119	0.7809	L	0.45051	1.395	0.80722	D	1	B	0.20261	0.043	B	0.19148	0.024	D	0.88186	0.2874	10	0.27785	T	0.31	-1.9885	11.5047	0.50459	0.0811:0.0:0.9189:0.0	.	302	Q5TBB1	RNH2B_HUMAN	R	302	ENSP00000337623:G302R	ENSP00000337623:G302R	G	+	1	0	RNASEH2B	50428576	1.000000	0.71417	1.000000	0.80357	0.519000	0.34347	4.167000	0.58209	2.871000	0.98454	0.655000	0.94253	GGG	RNASEH2B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000045006.3	8.625173	KEEP		+	8.668748	0.6	3	2	---	---	---	---	1	0.9999907	33	66	0	42	3	2	0	42	2	0	0	0	0	0	0	3	2	0	42	2	TP
PCDH20	64881	broad.mit.edu	37	13	61985658	61985658	+	Silent	SNP	T	T	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr13:61985658T>C	ENST00000409186.1	-	5	4679	c.2574A>G	c.(2572-2574)agA>agG	p.R858R	PCDH20_ENST00000409204.4_Silent_p.R858R			Q8N6Y1	PCD20_HUMAN	protocadherin 20	831		NA			homophilic cell adhesion	integral to membrane|plasma membrane	calcium ion binding			breast(3)|central_nervous_system(2)|endometrium(3)|kidney(4)|large_intestine(14)|liver(1)|lung(23)|ovary(5)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	58		Breast(118;0.195)|Prostate(109;0.229)		GBM - Glioblastoma multiforme(99;0.000118)		CTGGTTCTTTTCTTAAAAGAC	0.408	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						74	72	72	NA		NA	NA	13		NA											NA				61985658		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000197991	HGNC:14257	NM_022843	Approved	uc001vid.4	NA	B1AQU2|Q8NDN4|Q9NRT9	ENST00000409186.1	37	CCDS9442.2																																																																																			PCDH20-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000333054.2	-3.020577	KEEP		-	21.08981	0.070866	9	118	---	---	---	---	1	0.9526897	11	57	0	123	11	137	0	123	2	0	0	0	0	0	0	11	137	0	123	2	TP
SCAMP5	192683	broad.mit.edu	37	15	75305137	75305137	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr15:75305137C>T	ENST00000361900.6	+	4	334	c.127C>T	c.(127-129)Ctc>Ttc	p.L43F	SCAMP5_ENST00000425597.3_Missense_Mutation_p.L43F|SCAMP5_ENST00000562212.1_Missense_Mutation_p.L43F|SCAMP5_ENST00000565923.1_3'UTR|SCAMP5_ENST00000545456.1_Missense_Mutation_p.P24L	NM_001178111.1	NP_001171582.1	Q8TAC9	SCAM5_HUMAN	secretory carrier membrane protein 5	43		NA			exocytosis|negative regulation of endocytosis|positive regulation of calcium ion-dependent exocytosis|positive regulation of cytokine secretion|protein transport|response to endoplasmic reticulum stress	cell junction|integral to membrane|recycling endosome membrane|synaptic vesicle membrane|trans-Golgi network membrane	protein binding			large_intestine(1)|lung(1)|ovary(1)|urinary_tract(2)	5						CCTCTACTACCTCTGGATGTG	0.607	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						72	72	72	NA		NA	NA	15		NA											NA				75305137		2050	4192	6242	SO:0001583	missense				HGNC:30386	NM_138967	Approved	uc002azk.2	NA	B3KPJ7|B7Z762|D3DW71|Q8N3M4	ENST00000361900.6	37	CCDS45306.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	23.0|23.0	4.356580|4.356580	0.82243|0.82243	.|.	.|.	ENSG00000198794|ENSG00000198794	ENST00000361900;ENST00000425597|ENST00000545456	T;T|T	0.21031|0.21734	2.03;2.03|1.99	4.79|4.79	4.79|4.79	0.61399|0.61399	.|.	0.125475|.	0.56097|.	D|.	0.000034|.	T|T	0.30230|0.30230	0.0758|0.0758	M|M	0.84846|0.84846	2.72|2.72	0.31262|0.31262	N|N	0.69278|0.69278	D;D|B	0.76494|0.10296	0.999;0.999|0.003	D;D|B	0.83275|0.09377	0.964;0.996|0.004	T|T	0.28870|0.28870	-1.0030|-1.0030	10|9	0.66056|0.66056	D|D	0.02|0.02	-7.2444|-7.2444	10.5733|10.5733	0.45212|0.45212	0.0:0.912:0.0:0.088|0.0:0.912:0.0:0.088	.|.	43;43|24	Q8TAC9-2;Q8TAC9|Q8TAC9-3	.;SCAM5_HUMAN|.	F|L	43|24	ENSP00000355387:L43F;ENSP00000406547:L43F|ENSP00000439685:P24L	ENSP00000355387:L43F|ENSP00000439685:P24L	L|P	+|+	1|2	0|0	SCAMP5|SCAMP5	73092190|73092190	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	4.716000|4.716000	0.61916|0.61916	2.488000|2.488000	0.83962|0.83962	0.609000|0.609000	0.83330|0.83330	CTC|CCT	SCAMP5-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000420015.2	50.725087	KEEP		+	52.870284	0.3	18	42	---	---	---	---	1	1	151	73	0	79	22	59	0	79	2	0	0	0	0	0	0	22	59	0	79	2	TP
GDE1	51573	broad.mit.edu	37	16	19514711	19514711	+	3'UTR	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr16:19514711G>A	ENST00000353258.3	-	0	1257				CTA-363E6.7_ENST00000569345.1_RNA	NM_016641.3	NP_057725.1	Q9NZC3	GDE1_HUMAN	glycerophosphodiester phosphodiesterase 1	NA		NA			glycerol metabolic process|lipid metabolic process	cytoplasm|integral to membrane	glycerophosphodiester phosphodiesterase activity|glycerophosphoinositol glycerophosphodiesterase activity|metal ion binding			central_nervous_system(1)|endometrium(2)|large_intestine(1)|lung(6)|ovary(2)|prostate(1)	13						CCCAGGGCCTGGGCTAGCACA	0.507	NA	NA									OREG0023659	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000006007	HGNC:29644	NM_016641	Approved	uc002dgh.3	733	O43334|Q6PKF7|Q7KYR4	ENST00000353258.3	37	CCDS10578.1																																																																																			GDE1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254274.2	90.584601	KEEP		-	93.331124	0.783784	29	8	---	---	---	---	1	1	120	190	0	31	30	8	0	31	2	0	0	0	0	0	0	30	8	0	31	2	TP
ARMC5	79798	broad.mit.edu	37	16	31471307	31471307	+	Silent	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr16:31471307C>T	ENST00000457010.2	+	1	1163	c.462C>T	c.(460-462)ggC>ggT	p.G154G	ARMC5_ENST00000268314.4_Silent_p.G154G|ARMC5_ENST00000408912.3_Silent_p.G249G|RP11-452L6.5_ENST00000564629.1_RNA|ARMC5_ENST00000538189.1_Silent_p.G186G|ARMC5_ENST00000563544.1_Silent_p.G154G|ARMC5_ENST00000412665.2_5'UTR	NM_024742.2	NP_079018.1	Q96C12	ARMC5_HUMAN	armadillo repeat containing 5	154		NA					binding			central_nervous_system(1)|endometrium(4)|large_intestine(3)|liver(2)|lung(12)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)	28						GACTCGGAGGCATACTCCCTT	0.597	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						53	57	56	NA		NA	NA	16		NA											NA				31471307		2026	4178	6204	SO:0001819	synonymous_variant			ENSG00000140691	HGNC:25781	NM_024742	Approved	uc002ecc.3	NA	Q86WM9|Q9H7P8|Q9H925	ENST00000457010.2	37	CCDS42155.1																																																																																			ARMC5-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000432846.1	67.453696	KEEP		+	68.100594	0.647059	22	12	---	---	---	---	1	1	26	20	0	179	31	14	0	179	2	0	0	0	0	0	0	31	14	0	179	2	TP
TP53	7157	broad.mit.edu	37	17	7578268	7578268	+	Missense_Mutation	SNP	A	A	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr17:7578268A>C	ENST00000420246.2	-	6	713	c.581T>G	c.(580-582)cTt>cGt	p.L194R	TP53_ENST00000359597.4_Missense_Mutation_p.L194R|TP53_ENST00000455263.2_Missense_Mutation_p.L194R|TP53_ENST00000413465.2_Missense_Mutation_p.L194R|TP53_ENST00000269305.4_Missense_Mutation_p.L194R|TP53_ENST00000445888.2_Missense_Mutation_p.L194R|TP53_ENST00000574684.1_Intron	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	194	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	L -> F (in sporadic cancers; somatic mutation).|L -> H (in sporadic cancers; somatic mutation).|L -> I (in sporadic cancers; somatic mutation).|L -> P (in sporadic cancers; somatic mutation).|L -> R (in sporadic cancers; somatic mutation).|L -> V (in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.L194R(47)|p.L194P(8)|p.L194H(8)|p.0?(8)|p.?(6)|p.L101R(5)|p.L62R(5)|p.A189_V197delAPPQHLIRV(4)|p.P191_E198>Q(3)|p.P191fs*53(2)|p.P191fs*6(1)|p.H193_I195delHLI(1)|p.P59_E66>Q(1)|p.L194fs*15(1)|p.L194fs*14(1)|p.L101H(1)|p.L194fs*52(1)|p.P98_E105>Q(1)|p.A189fs*53(1)|p.L62H(1)|p.I195fs*52(1)|p.H193_I195>AP(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		CACTCGGATAAGATGCTGAGG	0.552	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	108	Substitution - Missense(75)|Whole gene deletion(8)|Deletion - Frameshift(6)|Complex - deletion inframe(6)|Unknown(6)|Deletion - In frame(5)|Insertion - Frameshift(1)|Complex - frameshift(1)	breast(19)|lung(14)|ovary(14)|large_intestine(11)|haematopoietic_and_lymphoid_tissue(10)|urinary_tract(6)|oesophagus(6)|biliary_tract(5)|skin(5)|bone(4)|upper_aerodigestive_tract(3)|stomach(3)|central_nervous_system(2)|pancreas(2)|liver(2)|soft_tissue(1)|prostate(1)					NA						97	87	90	NA		NA	NA	17		NA											NA				7578268		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	A	16.11	3.029856	0.54790	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99856	-7.21;-7.21;-7.21;-7.21;-7.21;-7.21;-7.21;-7.21	5.41	5.41	0.78517	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99869	0.9938	M	0.90425	3.115	0.80722	D	1	D;D;D;D;D;D;D	0.89917	1.0;1.0;0.999;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D	0.97110	1.0;1.0;0.984;1.0;1.0;1.0;1.0	D	0.96375	0.9277	10	0.87932	D	0	-29.6709	13.709	0.62656	1.0:0.0:0.0:0.0	.	155;194;194;101;194;194;194	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	R	194;194;194;194;194;194;183;101;62;101;62	ENSP00000410739:L194R;ENSP00000352610:L194R;ENSP00000269305:L194R;ENSP00000398846:L194R;ENSP00000391127:L194R;ENSP00000391478:L194R;ENSP00000425104:L62R;ENSP00000423862:L101R	ENSP00000269305:L194R	L	-	2	0	TP53	7518993	1.000000	0.71417	0.300000	0.25030	0.031000	0.12232	9.287000	0.95975	2.183000	0.69458	0.533000	0.62120	CTT	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	36.856988	KEEP		-	38.654629	0.288889	13	32	---	---	---	---	1	1	100	266	0	82	22	44	0	82	2	1	1	173	359	2	899	22	44	0	82	11	TP
TP53	7157	broad.mit.edu	37	17	7578542	7578542	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr17:7578542G>A	ENST00000420246.2	-	5	520	c.388C>T	c.(388-390)Ctc>Ttc	p.L130F	TP53_ENST00000359597.4_Missense_Mutation_p.L130F|TP53_ENST00000455263.2_Missense_Mutation_p.L130F|TP53_ENST00000413465.2_Missense_Mutation_p.L130F|TP53_ENST00000269305.4_Missense_Mutation_p.L130F|TP53_ENST00000445888.2_Missense_Mutation_p.L130F|TP53_ENST00000574684.1_5'Flank	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	130	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	L -> F (in sporadic cancers; somatic mutation).|L -> H (in sporadic cancers; somatic mutation).|L -> I (in a sporadic cancer; somatic mutation).|L -> P (in sporadic cancers; somatic mutation).|L -> R (in sporadic cancers; somatic mutation).|L -> V (in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.L130F(16)|p.L130V(11)|p.0?(8)|p.Y126_K132delYSPALNK(6)|p.L37F(3)|p.Y126_N131delYSPALN(3)|p.L130fs*19(2)|p.Y126fs*11(1)|p.S127_Q136del10(1)|p.A129_L130insXX(1)|p.A129_N131delALN(1)|p.V73fs*9(1)|p.Y126fs*18(1)|p.L130fs*39(1)|p.L130fs*16(1)|p.A129_K132delALNK(1)|p.L130_M133delLNKM(1)|p.N131fs*27(1)|p.P13fs*18(1)|p.S127fs*36(1)|p.L130del(1)|p.L130fs*40(1)|p.L130fs*41(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		ATCTTGTTGAGGGCAGGGGAG	0.552	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	65	Substitution - Missense(30)|Deletion - In frame(14)|Deletion - Frameshift(9)|Whole gene deletion(8)|Insertion - Frameshift(3)|Insertion - In frame(1)	large_intestine(11)|breast(9)|ovary(6)|upper_aerodigestive_tract(5)|lung(5)|central_nervous_system(4)|haematopoietic_and_lymphoid_tissue(4)|prostate(4)|bone(4)|urinary_tract(3)|oesophagus(3)|adrenal_gland(2)|stomach(2)|biliary_tract(1)|skin(1)|liver(1)					NA						45	46	45	NA		NA	NA	17		NA											NA				7578542		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	G	19.83	3.900016	0.72754	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000514944;ENST00000508793	D;D;D;D;D;D;D;D	0.99873	-7.38;-7.38;-7.38;-7.38;-7.38;-7.38;-7.38;-7.38	5.48	5.48	0.80851	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99885	0.9945	M	0.91300	3.195	0.58432	D	0.999998	D;D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D	0.97110	0.988;1.0;0.999;0.96;1.0;1.0;0.999	D	0.96542	0.9401	10	0.87932	D	0	-29.0594	17.2272	0.86973	0.0:0.0:1.0:0.0	.	91;130;130;37;130;130;130	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	F	130;130;130;130;130;130;119;37;37;130	ENSP00000410739:L130F;ENSP00000352610:L130F;ENSP00000269305:L130F;ENSP00000398846:L130F;ENSP00000391127:L130F;ENSP00000391478:L130F;ENSP00000423862:L37F;ENSP00000424104:L130F	ENSP00000269305:L130F	L	-	1	0	TP53	7519267	1.000000	0.71417	0.930000	0.37139	0.764000	0.43329	5.638000	0.67861	2.733000	0.93635	0.655000	0.94253	CTC	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	77.333808	KEEP		-	77.944988	0.638889	23	13	---	---	---	---	1	1	269	103	0	46	30	14	0	46	2	1	1	72	42	0	201	30	14	0	46	2	TP
ERBB2	2064	broad.mit.edu	37	17	37866667	37866667	+	Silent	SNP	G	G	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr17:37866667G>A	ENST00000406381.2	+	9	1254	c.744G>A	c.(742-744)acG>acA	p.T248T	ERBB2_ENST00000540147.1_Silent_p.T248T|ERBB2_ENST00000445658.2_Intron|ERBB2_ENST00000540042.1_Silent_p.T248T|ERBB2_ENST00000584450.1_Silent_p.T278T|ERBB2_ENST00000541774.1_Silent_p.T263T|ERBB2_ENST00000584601.1_Silent_p.T248T|ERBB2_ENST00000269571.5_Silent_p.T278T|ERBB2_ENST00000578199.1_Silent_p.T248T	NM_001005862.1	NP_001005862.1	P04626	ERBB2_HUMAN	v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2	278		NA			cell proliferation|heart development|phosphatidylinositol 3-kinase cascade|phosphatidylinositol-mediated signaling|positive regulation of cell adhesion|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|protein autophosphorylation|regulation of angiogenesis|regulation of microtubule-based process|regulation of transcription, DNA-dependent|transcription, DNA-dependent|wound healing	integral to membrane|nucleus|perinuclear region of cytoplasm|receptor complex	ATP binding|DNA binding|epidermal growth factor receptor activity|ErbB-3 class receptor binding|identical protein binding|protein C-terminus binding|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity			NS(1)|breast(16)|central_nervous_system(17)|endometrium(6)|haematopoietic_and_lymphoid_tissue(8)|kidney(4)|large_intestine(16)|liver(3)|lung(125)|ovary(18)|pancreas(1)|prostate(4)|skin(1)|stomach(14)|upper_aerodigestive_tract(9)|urinary_tract(4)	247	all_cancers(6;1.06e-93)|all_epithelial(6;2.33e-113)|Breast(7;9.37e-100)|Lung NSC(9;9.76e-10)|all_lung(9;5.34e-09)|Colorectal(19;0.000442)|Esophageal squamous(10;0.052)	Ovarian(249;0.0547)|Colorectal(1115;0.234)	UCEC - Uterine corpus endometrioid carcinoma (11;0.000126)|Epithelial(3;9.42e-64)|all cancers(3;5.61e-57)|BRCA - Breast invasive adenocarcinoma(8;2.5e-45)|STAD - Stomach adenocarcinoma(3;9.03e-13)|Colorectal(5;6.23e-08)|COAD - Colon adenocarcinoma(5;8.58e-06)|Lung(15;0.00193)|LUAD - Lung adenocarcinoma(14;0.0664)|OV - Ovarian serous cystadenocarcinoma(8;0.0917)|LUSC - Lung squamous cell carcinoma(15;0.171)	UCEC - Uterine corpus endometrioid carcinoma (308;0.0767)	Lapatinib(DB01259)|Letrozole(DB01006)|Trastuzumab(DB00072)	ACACAGACACGTTTGAGTCCA	0.582	NA	1	"""A, Mis, O"""		"""breast, ovarian, other tumour types, NSCLC, gastric"""					TCGA GBM(5;<1E-08)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		17	17q21.1	2064	"""v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)"""		E	0							NA						107	88	95	NA		NA	NA	17		NA											NA				37866667		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:3430		Approved	uc002hso.3	NA	B2RZG3|B4DHN3|Q14256|Q6LDV1|Q9UMK4	ENST00000406381.2	37	CCDS45667.1																																																																																			ERBB2-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		9.956127	KEEP		+	25.758503	0.106796	11	92	---	---	---	---	1	0.9823762	37	20	0	98	15	123	0	98	2	0	0	0	0	0	0	15	123	0	98	2	TP
RP11-798G7.5	0	broad.mit.edu	37	17	43585698	43585698	+	RNA	SNP	A	A	C	rs151148960	by1000genomes	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr17:43585698A>C	ENST00000253803.2	+	0	267				LRRC37A4P_ENST00000579913.1_RNA						NA		NA									NA						ATGCGTGATTATTTACTCTTG	0.448	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA										NA		ENST00000253803.2	37		.	.	.	.	.	.	.	.	.	.	A	0.084	-1.178475	0.01633	.	.	ENSG00000214425	ENST00000398305	.	.	.	3.47	1.22	0.21188	.	.	.	.	.	T	0.11067	0.0270	.	.	.	.	.	.	.	.	.	.	.	.	T	0.36407	-0.9749	4	0.02654	T	1	.	2.5051	0.04643	0.2372:0.1312:0.0:0.6316	.	.	.	.	K	43	.	ENSP00000381350:N43K	N	-	3	2	AC091132.2	40941481	0.809000	0.29036	0.007000	0.13788	0.003000	0.03518	0.362000	0.20284	0.537000	0.28751	-0.356000	0.07607	AAT	RP11-798G7.5-201	KNOWN	basic	antisense	NA	antisense		-16.178759	KEEP		+	8.317172	0.037736	4	102	---	---	---	---	1	0.399957	2	34	0	77	4	121	0	77	2	0	0	0	0	0	0	4	121	0	77	2	TP
ZNF443	10224	broad.mit.edu	37	19	12543219	12543219	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr19:12543219G>T	ENST00000301547.5	-	3	360	c.163C>A	c.(163-165)Caa>Aaa	p.Q55K	CTD-3105H18.16_ENST00000595562.1_Intron	NM_005815.4	NP_005806.2	Q9Y2A4	ZN443_HUMAN	zinc finger protein 443	55	KRAB.	NA			induction of apoptosis|regulation of transcription, DNA-dependent|response to stress|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(3)|endometrium(1)|kidney(1)|large_intestine(11)|lung(10)|pancreas(1)|prostate(1)	28						TATCTATATTGATCTTCAATG	0.294	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						69	77	74	NA		NA	NA	19		NA											NA				12543219		2201	4292	6493	SO:0001583	missense			ENSG00000180855	HGNC:20878	NM_005815	Approved	uc002mtu.3	NA		ENST00000301547.5	37	CCDS32918.1	.	.	.	.	.	.	.	.	.	.	G	6.120	0.390380	0.11581	.	.	ENSG00000180855	ENST00000301547;ENST00000411622	T	0.00792	5.69	1.13	1.13	0.20643	Krueppel-associated box (3);	.	.	.	.	T	0.00608	0.0020	N	0.21617	0.685	0.20873	N	0.999839	B	0.20671	0.047	B	0.14023	0.01	T	0.46693	-0.9173	9	0.26408	T	0.33	.	3.5149	0.07721	0.2599:0.0:0.74:0.0	.	55	Q9Y2A4	ZN443_HUMAN	K	55	ENSP00000301547:Q55K	ENSP00000301547:Q55K	Q	-	1	0	ZNF443	12404219	0.000000	0.05858	0.084000	0.20598	0.179000	0.23085	-0.854000	0.04299	0.960000	0.38005	0.433000	0.28618	CAA	ZNF443-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000344084.1	94.510403	KEEP		-	95.22967	0.636364	28	16	---	---	---	---	1	0.9999696	7	3	0	125	39	23	0	125	2	0	0	0	0	0	0	39	23	0	125	2	TP
MAG	4099	broad.mit.edu	37	19	35801000	35801000	+	Silent	SNP	C	C	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr19:35801000C>T	ENST00000361922.4	+	8	1605	c.1455C>T	c.(1453-1455)cgC>cgT	p.R485R	MAG_ENST00000593348.1_3'UTR|MAG_ENST00000537831.2_Silent_p.R460R|MAG_ENST00000392213.3_Silent_p.R485R	NM_080600.2	NP_542167.1	P20916	MAG_HUMAN	myelin associated glycoprotein	485	Ig-like C2-type 4.	NA			blood coagulation|cell adhesion|leukocyte migration|negative regulation of axonogenesis|nerve growth factor receptor signaling pathway	integral to membrane|plasma membrane	sugar binding			NS(1)|breast(4)|central_nervous_system(1)|endometrium(3)|large_intestine(10)|lung(11)|skin(2)|upper_aerodigestive_tract(2)	34	all_lung(56;2.37e-08)|Lung NSC(56;3.66e-08)|Esophageal squamous(110;0.162)	Renal(1328;0.242)	Epithelial(14;3.14e-19)|OV - Ovarian serous cystadenocarcinoma(14;1.5e-18)|all cancers(14;1.5e-16)|LUSC - Lung squamous cell carcinoma(66;0.0417)			CCCCGCCCCGCGTCATCTGCA	0.697	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						34	34	34	NA		NA	NA	19		NA											NA				35801000		2202	4296	6498	SO:0001819	synonymous_variant			ENSG00000105695	HGNC:6783	NM_080600	Approved	uc002nyy.2	NA		ENST00000361922.4	37	CCDS12456.1																																																																																			MAG-002	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000466072.1	92.191028	KEEP		+	94.292349	0.74359	29	10	---	---	---	---	1	1	98	635	0	74	42	13	0	74	2	0	0	0	0	0	0	42	13	0	74	2	TP
ZNF28	7576	broad.mit.edu	37	19	53304049	53304049	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr19:53304049G>T	ENST00000438150.2	-	2	1783	c.890C>A	c.(889-891)aCt>aAt	p.T297N	ZNF28_ENST00000457749.2_Missense_Mutation_p.T350N|ZNF28_ENST00000414252.2_Missense_Mutation_p.T297N|ZNF28_ENST00000360272.4_Missense_Mutation_p.T297N			P17035	ZNF28_HUMAN	zinc finger protein 28	350		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(2)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(11)|liver(1)|lung(10)|skin(3)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	34				GBM - Glioblastoma multiforme(134;0.0386)|Lung(386;0.145)		TTTCTCTCCAGTGTGAATTAT	0.373	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						93	96	95	NA		NA	NA	19		NA											NA				53304049		2203	4300	6503	SO:0001583	missense			ENSG00000198538	HGNC:13073	NM_006969	Approved	uc002qad.3	NA	A8KAK9|B4E3G0|B9EIK7|Q5H9V1|Q5HYM9|Q6ZML9|Q6ZN56	ENST00000438150.2	37		.	.	.	.	.	.	.	.	.	.	-	10.97	1.500315	0.26861	.	.	ENSG00000198538	ENST00000438150;ENST00000457749;ENST00000360272;ENST00000414252;ENST00000391783	T;T;T;T;T	0.26067	1.76;1.76;1.76;1.76;1.76	1.74	0.511	0.16989	Zinc finger, C2H2 (1);Zinc finger, C2H2-type/integrase, DNA-binding (1);	.	.	.	.	T	0.41719	0.1171	L	0.53671	1.685	0.21984	N	0.999436	P	0.46142	0.873	D	0.67382	0.951	T	0.24225	-1.0166	9	0.72032	D	0.01	.	8.6557	0.34062	0.0:0.2394:0.7606:0.0	.	350	P17035	ZNF28_HUMAN	N	297;350;297;297;297	ENSP00000412143:T297N;ENSP00000397693:T350N;ENSP00000353410:T297N;ENSP00000444965:T297N;ENSP00000375661:T297N	ENSP00000353410:T297N	T	-	2	0	ZNF28	57995861	0.856000	0.29760	0.600000	0.28864	0.161000	0.22273	1.369000	0.34227	0.042000	0.15717	0.186000	0.17326	ACT	ZNF28-004	PUTATIVE	alternative_5_UTR|basic	protein_coding	NA	protein_coding	OTTHUMT00000396147.2	320.207001	KEEP		-	327.735242	0.758065	94	30	---	---	---	---	1	1	8	7	0	215	117	46	0	215	2	0	0	0	0	0	0	117	46	0	215	2	TP
ZNF347	84671	broad.mit.edu	37	19	53643809	53643809	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr19:53643809T>C	ENST00000452676.2	-	5	2701	c.2275A>G	c.(2275-2277)Att>Gtt	p.I759V	ZNF347_ENST00000334197.7_Missense_Mutation_p.I758V|ZNF347_ENST00000601804.1_Intron|ZNF347_ENST00000601469.2_Missense_Mutation_p.I759V	NM_001172674.1	NP_001166145.1	Q96SE7	ZN347_HUMAN	zinc finger protein 347	758		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			endometrium(3)|kidney(2)|large_intestine(6)|lung(8)|prostate(3)|skin(1)	23				GBM - Glioblastoma multiforme(134;0.0179)		CCAGTATGAATTCCCCGATGT	0.418	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(64;205 1597 17324 45721)							NA				0							NA						159	153	155	NA		NA	NA	19		NA											NA				53643809		2203	4300	6503	SO:0001583	missense				HGNC:16447	NM_032584	Approved	uc010eql.2	NA	B9EG59|Q8TCN1	ENST00000452676.2	37	CCDS54314.1	.	.	.	.	.	.	.	.	.	.	T	4.439	0.081242	0.08533	.	.	ENSG00000197937	ENST00000334197;ENST00000452676	T;T	0.00986	5.47;5.47	3.16	0.963	0.19649	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);	.	.	.	.	T	0.00468	0.0015	N	0.02674	-0.535	0.19300	N	0.99997	B;B	0.09022	0.001;0.002	B;B	0.14578	0.006;0.011	T	0.46176	-0.9210	9	0.29301	T	0.29	.	2.8586	0.05579	0.188:0.2185:0.0:0.5935	.	759;758	G5E9N4;Q96SE7	.;ZN347_HUMAN	V	758;759	ENSP00000334146:I758V;ENSP00000405218:I759V	ENSP00000334146:I758V	I	-	1	0	ZNF347	58335621	0.000000	0.05858	0.006000	0.13384	0.029000	0.11900	-0.085000	0.11250	0.019000	0.15079	0.533000	0.62120	ATT	ZNF347-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000464172.2	-49.393694	KEEP		-	6.969701	0.018519	4	212	---	---	---	---	1	0.1543688	5	23	0	400	6	278	0	400	2	0	0	0	0	0	0	6	278	0	400	2	TP
TSHZ2	128553	broad.mit.edu	37	20	51870661	51870661	+	Missense_Mutation	SNP	G	G	A	rs141167641	by1000genomes	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr20:51870661G>A	ENST00000371497.5	+	2	1551	c.664G>A	c.(664-666)Gcg>Acg	p.A222T	TSHZ2_ENST00000603338.2_Missense_Mutation_p.A219T|RP4-678D15.1_ENST00000606932.1_RNA|TSHZ2_ENST00000329613.6_Missense_Mutation_p.A219T	NM_001193421.1|NM_173485.5	NP_001180350.1|NP_775756.3	Q9NRE2	TSH2_HUMAN	teashirt zinc finger homeobox 2	222		NA			multicellular organismal development	nucleus	sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|zinc ion binding	p.A222T(1)		NS(2)|breast(4)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(2)|kidney(3)|large_intestine(16)|lung(38)|ovary(5)|prostate(2)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(2)	84			STAD - Stomach adenocarcinoma(23;0.1)			ACAGTGCAGCGCGGCCTATGA	0.562	NA	NA											G	1	5e-04	NA	NA	2184	NA	1	,	,	NA	3e-04	0.0013	NA	NA	5e-04	1	LOWCOV,EXOME	NA	NA	3e-04	SNP								NA				1	Substitution - Missense(1)	ovary(1)					NA						57	52	53	NA		NA	NA	20		NA											NA				51870661		2203	4300	6503	SO:0001583	missense			ENSG00000182463	HGNC:13010	NM_173485	Approved	uc021wex.1	NA	Q4VXM4|Q6N003|Q8N260	ENST00000371497.5	37	CCDS33490.1	1	4.578754578754579E-4	0	0.0	0	0.0	0	0.0	1	0.0013192612137203166	G	24.9	4.584970	0.86748	.	.	ENSG00000182463	ENST00000371497;ENST00000329613	T;T	0.16073	2.37;2.37	5.2	5.2	0.72013	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (1);	0.000000	0.85682	D	0.000000	T	0.41213	0.1149	L	0.59436	1.845	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	T	0.17715	-1.0360	10	0.66056	D	0.02	-21.8975	19.0899	0.93223	0.0:0.0:1.0:0.0	.	222	Q9NRE2	TSH2_HUMAN	T	222;219	ENSP00000360552:A222T;ENSP00000333114:A219T	ENSP00000333114:A219T	A	+	1	0	TSHZ2	51304068	1.000000	0.71417	0.730000	0.30809	0.640000	0.38277	9.414000	0.97362	2.579000	0.87056	0.643000	0.83706	GCG	TSHZ2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000080398.6	77.648445	KEEP		+	85.625107	0.242424	32	100	---	---	---	---	1	0.6744983	3	5	0	71	43	118	0	71	2	0	0	0	0	0	0	43	118	0	71	2	TP
MIS18A	54069	broad.mit.edu	37	21	33641251	33641251	+	3'UTR	SNP	C	C	T	rs11557587		GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr21:33641251C>T	ENST00000290130.3	-	0	853				MIS18A_ENST00000486363.1_5'Flank	NM_018944.2	NP_061817.1	Q9NYP9	MS18A_HUMAN	MIS18 kinetochore protein A	NA		NA			cell division|CenH3-containing nucleosome assembly at centromere|mitosis	chromosome, centromeric region|nucleoplasm				breast(1)|endometrium(1)|kidney(2)|large_intestine(1)|lung(2)	7						ttttttttttctttttttttt	0.478	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000159055	HGNC:1286	NM_018944	Approved	uc002ypi.3	NA	B2R562|Q542Z0	ENST00000290130.3	37	CCDS13611.1																																																																																			MIS18A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000193090.1	3.307805	KEEP		-	6.849419	0.12	3	22	---	---	---	---	1	0.9956379	2	71	0	32	6	37	0	32	2	0	0	0	0	0	0	6	37	0	32	2	TP
C21orf62	56245	broad.mit.edu	37	21	34166090	34166090	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chr21:34166090C>G	ENST00000536776.1	-	2	783	c.643G>C	c.(643-645)Gtc>Ctc	p.V215L	C21orf49_ENST00000382375.4_Intron|C21orf49_ENST00000453404.1_Intron|C21orf49_ENST00000382377.3_Intron|C21orf49_ENST00000477513.1_Intron|C21orf62_ENST00000490358.1_Missense_Mutation_p.V215L|C21orf62_ENST00000479548.1_Missense_Mutation_p.V215L|C21orf49_ENST00000382378.1_Intron|C21orf62_ENST00000487113.1_Missense_Mutation_p.V215L	NM_001162495.2|NM_001162496.2|NM_019596.5	NP_001155967.2|NP_001155968.2|NP_062542.5	Q9NYP8	CU062_HUMAN	chromosome 21 open reading frame 62	215		NA								endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(1)|lung(2)|ovary(1)	6		Myeloproliferative disorder(46;0.0255)				ATAAATGTGACAACATAGCTT	0.368	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						108	101	103	NA		NA	NA	21		NA											NA				34166090		1881	4110	5991	SO:0001583	missense			ENSG00000205929	HGNC:1305	NM_019596	Approved	uc011adu.2	NA	A8K4L8	ENST00000536776.1	37	CCDS42919.2	.	.	.	.	.	.	.	.	.	.	C	18.97	3.736690	0.69304	.	.	ENSG00000205929	ENST00000536776;ENST00000490358;ENST00000487113;ENST00000382373;ENST00000479548	.	.	.	5.88	4.07	0.47477	.	.	.	.	.	T	0.68778	0.3038	M	0.68952	2.095	0.42010	D	0.990936	D	0.61697	0.99	P	0.60173	0.87	T	0.72697	-0.4215	8	0.66056	D	0.02	-15.5482	11.5805	0.50889	0.0:0.8559:0.0:0.1441	.	215	Q9NYP8	CU062_HUMAN	L	215;215;215;262;215	.	ENSP00000371810:V262L	V	-	1	0	C21orf62	33087961	0.973000	0.33851	0.913000	0.36048	0.853000	0.48598	2.300000	0.43620	1.496000	0.48567	0.561000	0.74099	GTC	C21orf62-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000139598.5	-34.780803	KEEP		-	12.807601	0.030457	6	191	---	---	---	---	1	0.7036455	13	77	0	170	6	231	0	170	2	0	0	0	0	0	0	6	231	0	170	2	TP
YIPF6	286451	broad.mit.edu	37	X	67731798	67731798	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-19-1390-Tumor-SM-17P32	GBM-TCGA-19-1390-Normal-SM-1QXYA	g.chrX:67731798T>A	ENST00000462683.1	+	2	909	c.165T>A	c.(163-165)aaT>aaA	p.N55K	YIPF6_ENST00000374622.2_Intron|YIPF6_ENST00000470730.1_3'UTR	NM_173834.3	NP_776195.2	Q96EC8	YIPF6_HUMAN	Yip1 domain family, member 6	55		NA				endoplasmic reticulum|integral to membrane				cervix(1)|endometrium(1)|kidney(1)|large_intestine(2)|lung(1)|urinary_tract(1)	7						CCACATTAAATGAATCTGTTC	0.393	NA	NA												NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA				0							NA						142	123	129	NA		NA	NA	X		NA											NA				67731798		2203	4300	6503	SO:0001583	missense			ENSG00000181704	HGNC:28304	NM_173834	Approved	uc004dwz.3	NA	Q5JP08	ENST00000462683.1	37	CCDS14389.1	.	.	.	.	.	.	.	.	.	.	T	16.23	3.064932	0.55432	.	.	ENSG00000181704	ENST00000462683	T	0.44482	0.92	5.66	1.99	0.26369	.	0.143111	0.64402	D	0.000009	T	0.30417	0.0764	L	0.36672	1.1	0.80722	D	1	B	0.15930	0.015	B	0.17433	0.018	T	0.09952	-1.0651	10	0.87932	D	0	2.3794	7.4814	0.27406	0.0:0.2631:0.0:0.7369	.	55	Q96EC8	YIPF6_HUMAN	K	55	ENSP00000417573:N55K	ENSP00000417573:N55K	N	+	3	2	YIPF6	67648523	1.000000	0.71417	0.996000	0.52242	0.896000	0.52359	1.116000	0.31221	0.279000	0.22186	-0.469000	0.05056	AAT	YIPF6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000057016.1	9.319854	KEEP		+	14.718254	0.139535	6	37	---	---	---	---	1	0.9981579	3	99	0	265	7	54	0	265	2	0	0	0	0	0	0	7	54	0	265	2	TP
